Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(-)-trans-delta-9-Tetrahydrocannabinol[1] Dronabinol[1] Dronabinol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
2(IM) AVONEX®----[1] 13 💬
3(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide----[1] 13 💬
40,5 mg Fingolimod[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
50.25 mg RPC1063----[3] 13, 96, 97 💬
60.25mg RPC1063----[2] 13, 97 💬
70.5 mg RPC1063----[2] 13, 97 💬
80.5mg RPC1063----[1] 13 💬
90.9% Chloride Injection Sodium----[1] 13 💬
101 - Andrographis paniculata p/st extract----[1] 13 💬
111 mg RPC1063----[2] 13, 97 💬
121% Steroid Cream----[1] 13 💬
131-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone----[1] 13 💬
141.0mg RPC1063----[1] 13 💬
1510 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)----[1] 13 💬
16100% Oxygen[1] Oxygen[1] Oxygen 💬 --[6] 13, 15, 36, 96, 97, 269 💬
1710000IU vitamin D[1] Vitamin D---[1] 13 💬
181000mg acetaminophen[1] Acetaminophen[1] Acetaminophen 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
1911C-BMS-986196----[1] 13 💬
2011C-MC1----[2] 6, 13 💬
2111C-PBR28----[2] 6, 13 💬
2211C-PiB----[2] 6, 13 💬
2311C-PS13----[2] 6, 13 💬
2413-PCV Booster----[1] 13 💬
2513-valent pneumococcal conjugate vaccine (13-PCV)----[1] 13 💬
2615 mg fampridine-SR (4-aminopyridine, 4-AP)----[1] 13 💬
2718F-DPA-714 and 18F-FDG----[1] 13 💬
2818F-OP-801----[3] 2, 6, 13 💬
2918F-PM-PBB3----[1] 13 💬
3019 nor vitamin d[1] Vitamin D---[1] 13 💬
312 - Excipients----[1] 13 💬
322 mA Transcranial Direct Current Stimulation----[1] 13 💬
332-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester[1] Famciclovir[1] Famciclovir 💬 --[1] 13 💬
342-CdA, 2-chloro-2'-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
352-CdA, 2-chloro-2'-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
362-CdA, 2-chloro-2?-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
372-CdA, 2-chloro-2?-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
382-CdA, 2-chloro-2’-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
392-CdA, 2-chloro-2’-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
402-chloro-2'-deoxy-beta-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
412-chloro-2'-deoxy-ß-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
422-chloro-2'-deoxyadenosine (2-CdA)[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
432-chloro-2'-deoxyadenosine, 2CdA[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
442-chloro-2?-deoxy-beta-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
452-chloro-2?-deoxy-ß-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
462-chloro-2’-deoxy-beta-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
472-chloro-2’-deoxy-beta-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
482-chloro-2’-deoxy-ß-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
492-chloro-2’-deoxy-ß-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
502-chloro-2’-deoxyadenosine (2-CdA)[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
5120 mg fampridine-SR (4-aminopyridine, 4-AP)----[1] 13 💬
5220 mg GA----[1] 13 💬
5320 mg MitoQ----[1] 13 💬
54200106 or EMD 28162----[1] 13 💬
5520mg/0.5ml GA----[1] 13 💬
5620mg/0.5ml glatiramer acetate[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
5723-PPV----[1] 13 💬
5823-valent pneumococcal polysaccharide vaccine----[3] 13, 46, 53 💬
5923-valent pneumococcal polysaccharide vaccine (23-PPV)----[1] 13 💬
6025(OH)D3----[1] 13 💬
6125OH-Vitamin D[1] Vitamin D---[1] 13 💬
622B3-201----[1] 13 💬
633 mg Melatonin[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 13 💬
643,4-DIAMINOPYRIDINE----[2] 12, 13 💬
654 mA Transcranial Direct Current Stimulation----[1] 13 💬
664-aminopyridine----[2] 3, 13 💬
674.5 mg Naltrexone[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
6840 mg GA----[2] 2, 13 💬
6940 mg glatiramer acetate[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[2] 2, 13 💬
7040 mg Glatiramer acetato[1] Glatiramer[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
7140mg of MitoQ----[1] 13 💬
725 mg Melatonin[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 13 💬
735000IU vitamin D[1] Vitamin D---[1] 13 💬
7452069.00.01----[1] 13 💬
757-day Fasting-Mimicking Diet (7-DAY FMD)----[1] 13 💬
7689 Zr-Df-crefmirlimab[1] Crefmirlimab---[2] 13, 25 💬
779060X----[2] 13, 149 💬
7895% Pure ECGC capsules 200mg----[1] 13 💬
79[ 18F]3F4AP----[1] 13 💬
80[032166011]----[1] 13 💬
81[033283045]----[1] 13 💬
82[034091165]----[1] 13 💬
83[035418060]----[1] 13 💬
84[11C]-PK-11195----[1] 13 💬
85[11C]flumazenil[1] Flumazenil[1] Flumazenil 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13 💬
86[11C]PIB----[1] 13 💬
87[123I]CLINDE----[2] 6, 13 💬
88[14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----[3] 13, 96, 97 💬
89[18F] FZTA----[1] 13 💬
90[18F] PBR06----[2] 6, 13 💬
91[18F]-FEPPA----[2] 6, 13 💬
92[18F]DPA-714----[2] 13, 127 💬
93[18F]Florbetapir PET imaging----[1] 13 💬
94[18F]MK6240----[1] 13 💬
95[18F]UCB-H----[1] 13 💬
96[AB1010]----[2] 2, 13 💬
97[ALXN1210]----[6] 2, 11, 13, 50, 62, 66 💬
98[BAF312]----[1] 13 💬
99[BIIB 017]----[1] 13 💬
100[BIIB017]----[1] 13 💬
101[BIIB033]----[1] 13 💬
102[C-11]Methylreboxetine----[1] 13 💬
103[C-11]PBR28----[1] 13 💬
104[C11]PK-1195 PET scan----[1] 13 💬
105[CLS12311]----[1] 13 💬
106[F-18]FDG----[1] 13 💬
107[F-18]PBR06----[1] 13 💬
108[F-18]SDM-8----[1] 13 💬
109[Formistin 10 mg]----[1] 13 💬
110[FTY720]----[1] 13 💬
111[HMR1726]----[1] 13 💬
112[IFN beta-1a]----[1] 13 💬
113[IFN ß-1a]----[1] 13 💬
114[JNJ-67896153/ACT-128800]----[1] 13 💬
115[L04AA31]----[1] 13 💬
116[LOU064C1]----[1] 13 💬
117[M2951]----[1] 13 💬
118[MD1003]----[1] 13 💬
119[Metilprednisolone]----[2] 13, 300 💬
120[N/A]----[11] 2, 11, 13, 20, 28, 46, 51, 61, 65, 97, 299 💬
121[NA]----[34] 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
122[non applicabile]----[1] 13 💬
123[Not Applicable]----[4] 13, 20, 50, 272 💬
124[OMB 157]----[1] 13 💬
125[OMB157]----[1] 13 💬
126[ozanimod cloridrato][1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
127[Ozanimod][1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
128[Ro 533-3787/F01- 04]----[1] 13 💬
129[Ro 533-3787/F01- 06]----[1] 13 💬
130[RO4964913/F07-01]----[1] 13 💬
131[RO4964913/F07]----[1] 13 💬
132[RO4964913]----[1] 13 💬
133[RO5333787]----[2] 11, 13 💬
134[RO7010939]----[1] 13 💬
135[SAR442168]----[2] 11, 13 💬
136[Siponimod 0, 25 mg][1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
137[Siponimod 2 mg][1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
138[Siponimod][1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
139[Soliris]----[2] 13, 62 💬
140[Tachipirina CPR 500mg]----[1] 13 💬
141[Zr-89]Oxine-labeled leukocytes PET/MRI----[1] 13 💬
142A4I Antagonist----[1] 13 💬
143AB1010----[6] 2, 5, 6, 13, 46, 96 💬
144ABA-101----[1] 13 💬
145Abatacept[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[28] 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
146Abobotulinumtoxin A----[1] 13 💬
147ABP 692----[1] 13 💬
148ABR-215062----[1] 13 💬
149ABR-215062 sodium salt----[2] 13, 96 💬
150ABT-555----[1] 13 💬
151ABT-874/Human monoclonal antibody against IL-12----[1] 13 💬
152ABX-1431[1] ABX-1431---[1] 13 💬
153ABX-1431 HCl[1] ABX-1431---[1] 13 💬
154Acetaminophen[1] Acetaminophen[1] Acetaminophen 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[19] 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
155Acetaminophen Tablet 650mg[1] Acetaminophen[1] Acetaminophen 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
156Acetate[1] Acetate---[52] 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
157Acetazolamide[1] Acetazolamide[2] Acetazolamide ,
Acetazolamide sodium 💬 		[13] CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬 		[6] Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬[8] 13, 67, 90, 115, 155, 222, 225, 230 💬
158Acetylcysteine[1] Acetylcysteine[1] Acetylcysteine 💬 --[25] 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
159ACETYLSALICYLIC ACID[1] Acetylsalicylic acid[1] Aspirin 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[5] 13, 46, 51, 62, 210 💬
160Acetylsalicylic acid at 1st visit,[1] Acetylsalicylic acid[1] Aspirin 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
161Aciclovir----[3] 13, 28, 60 💬
162Aclasta----[4] 13, 97, 271, 274 💬
163Aclasta 5 mg Infusionslösung----[1] 13 💬
164Aclasta 5mg solution for infusion----[1] 13 💬
165ACT----[1] 13 💬
166ACT-1----[1] 13 💬
167ACT-128800----[1] 13 💬
168ACT-128800 Dose 1----[1] 13 💬
169ACT-128800 Dose 2----[1] 13 💬
170ACT-128800 Dose 3----[1] 13 💬
171ACTH----[3] 13, 145, 222 💬
172Acthar----[6] 2, 13, 46, 49, 50, 222 💬
173Acthar Gel----[6] 13, 46, 49, 84, 222, 223 💬
174ACTHAR Gel (ACTH)----[1] 13 💬
175Activated charcoal[1] Activated charcoal[1] Charcoal, activated 💬 --[2] 13, 85 💬
176Active Comparator receiving Extavia®----[1] 13 💬
177Active Control----[1] 13 💬
178ACTOS (Pioglitazone)[1] Pioglitazone[2] Pioglitazone hydrochloride ,
Pioglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 13 💬
179Acyclovir[1] Acyclovir[2] Acyclovir ,
Acyclovir sodium 💬 		--[2] 13, 28 💬
180Ad26.COV2.S----[7] 13, 35, 46, 49, 50, 51, 107 💬
181Adderall XR----[1] 13 💬
182Adderall XR 10 mg----[1] 13 💬
183Adderall XR 5mg----[1] 13 💬
184Adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 13, 57, 58, 65 💬
185Adezunap----[1] 13 💬
186Adezunap (AP707)----[1] 13 💬
187Adipose tissue-derived Mesenchymal Stromal Cells----[1] 13 💬
188Adrenocorticotropic Hormone----[1] 13 💬
189Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)----[1] 13 💬
190ADS-5102----[2] 6, 13 💬
191ADS-5102, 137 mg----[1] 13 💬
192ADS-5102, 274 mg----[1] 13 💬
193AERT, (R)-Baclofen[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
194AGEE cream----[1] 13 💬
195AHSC----[1] 13 💬
196AI Device----[1] 13 💬
197AIMSPRO----[2] 13, 51 💬
198AIN----[1] 13 💬
199AIN457----[9] 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
200Alanine[1] Alanine[1] Alanine 💬 --[8] 6, 13, 70, 94, 97, 251, 298, 299 💬
201Albumin (Human) 25%, United States Pharmacopeia (USP)----[2] 13, 14 💬
202Albuterol[1] Albuterol[2] Albuterol sulfate ,
Albuterol 💬 		[1] ADRB2 💬 [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[9] 12, 13, 86, 89, 113, 231, 256, 299, 340 💬
203Alcohol Wipes vs. No Alcohol Wipes----[1] 13 💬
204ALEMTUZUMAB[1] Alemtuzumab[1] Alemtuzumab 💬 --[21] 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
205Alemtuzumab (GZ402673)[1] Alemtuzumab[1] Alemtuzumab 💬 --[1] 13 💬
206Alemtuzumab 12 mg[1] Alemtuzumab[1] Alemtuzumab 💬 --[1] 13 💬
207Alemtuzumab 24 mg[1] Alemtuzumab[1] Alemtuzumab 💬 --[1] 13 💬
208Alemtuzumab GZ402673[1] Alemtuzumab[1] Alemtuzumab 💬 --[1] 13 💬
209Alemtuzumab immunotherapy[1] Alemtuzumab[1] Alemtuzumab 💬 --[1] 13 💬
210Alemtuzumab Injection[1] Alemtuzumab[1] Alemtuzumab 💬 --[1] 13 💬
211Alemtuzumab Injection [Lemtrada][1] Alemtuzumab[1] Alemtuzumab 💬 --[1] 13 💬
212Alfuzosin[1] Alfuzosin[2] Alfuzosin hydrochloride ,
Alfuzosin 💬 		[1] ADRA1A 💬 [9] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 13 💬
213ALKS 8700----[1] 13 💬
214ALKS 8700 Delayed Release (DR)----[1] 13 💬
215ALKS 8700 Delayed Release (DR) Capsule----[1] 13 💬
216All patients in the study will be treated with ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
217Allogeneic fecal microbiota[1] Fecal microbiota---[1] 13 💬
218Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells----[1] 13 💬
219Allogeneic umbilical cord mesenchymal stem cells[1] Allogeneic umbilical cord mesenchymal stem cells---[1] 13 💬
220Allogenic placenta derived mesenchymal stem cells----[1] 13 💬
221AlloRx----[8] 2, 13, 46, 51, 85, 90, 97, 226 💬
222Alpha Lipoic Acid[1] Lipoic acid[1] Thioctic acid 💬 --[1] 13 💬
223ALPHA-LIPOIC ACID[1] Lipoic acid[1] Thioctic acid 💬 --[2] 2, 13 💬
224Alpha1-antitrypsin----[1] 13 💬
225ALTRI FARMACI DEL SISTEMA NERVOSO----[1] 13 💬
226ALXN1210----[7] 2, 11, 13, 50, 62, 66, 109 💬
227Amantadine[1] Amantadine[2] Amantadine hydrochloride ,
Amantadine 💬 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[5] 2, 6, 8, 13, 127 💬
228AMANTADINE HYDROCHLORIDE[1] Amantadine[2] Amantadine hydrochloride ,
Amantadine 💬 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[2] 6, 13 💬
229Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule[1] Amantadine[2] Amantadine hydrochloride ,
Amantadine 💬 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 13 💬
230Amantadine Level[1] Amantadine[2] Amantadine hydrochloride ,
Amantadine 💬 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 13 💬
231American ginseng extract HT-1001[1] Ginseng[2] Red ginseng ,
Ginseng 💬 		--[1] 13 💬
232Amiloride[1] Amiloride[2] Amiloride hydrochloride ,
Amiloride 💬 		[3] SCNN1A,
SCNN1B,
SCNN1G 💬 		[2] Aldosterone-regulated sodium reabsorption, Taste transduction 💬[5] 13, 67, 222, 225, 299 💬
233Amiloride Hydrochloride[1] Amiloride[2] Amiloride hydrochloride ,
Amiloride 💬 		[3] SCNN1A,
SCNN1B,
SCNN1G 💬 		[2] Aldosterone-regulated sodium reabsorption, Taste transduction 💬[1] 13 💬
234AMILORIDE HYDROCHLORIDE, 2 H2O[1] Amiloride[2] Amiloride hydrochloride ,
Amiloride 💬 		[3] SCNN1A,
SCNN1B,
SCNN1G 💬 		[2] Aldosterone-regulated sodium reabsorption, Taste transduction 💬[1] 13 💬
235Amilostad HCT----[1] 13 💬
236Amilostad HCT tablets----[1] 13 💬
237Amniotic fluid or placental CD117 stem cells----[1] 13 💬
238AMPYRA----[1] 13 💬
239Amyvid radiopharmaceutical----[1] 13 💬
240AN100226----[2] 13, 96 💬
241AN100226, BG00002----[1] 13 💬
242Anakinra[1] Anakinra[1] Anakinra 💬 [2] IL1R1,
IL1R2 💬 		[15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[22] 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
243AndroGel 1 % Topical Gel----[1] 13 💬
244Androgel 10 grams of gel containing 100 mg of testosterone[1] Testosterone[1] Testosterone 💬 [1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 13 💬
245Andrographolides----[1] 13 💬
246Anesthetic Topical Adhesive Synera----[1] 13 💬
247ANK-700----[1] 13 💬
248Anti LP40 antibody, subclass IgG4 LA294----[2] 13, 46 💬
249Anti-BAFFR CART----[1] 13 💬
250Anti-CD20 antibody----[2] 13, 64 💬
251Anti-CD20 mAB----[1] 13 💬
252Anti-CD20 Monoclonal Antibody----[1] 13 💬
253Anti-CD20 MS treatment----[1] 13 💬
254Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)[3] Ocrelizumab,
Ofatumumab,
Rituximab		[3] Rituximab ,
Ocrelizumab ,
Ofatumumab 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
255Anti-CD25 Humanized Monoclonal Antibody----[1] 13 💬
256Anti-CD52 monoclonal antibody----[1] 13 💬
257Anti-IL-12----[2] 13, 96 💬
258Anti-Mullerian hormone (AMH) level----[1] 13 💬
259Anti-Thymocyte Globulin----[19] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
260Anticholinergic medication----[1] 13 💬
261Anticuerpo monoclonal anti-LINGO-1 humano----[1] 13 💬
262Antihistamine----[3] 13, 19, 46 💬
263Antimycotic----[1] 13 💬
264Antithymocyte----[1] 13 💬
265ANTITHYMOCYTE IMMUNOGLOBULIN----[1] 13 💬
266Antithymocyte immunoglobulin (rabbit)[1] Rabbit---[2] 13, 96 💬
267Anxiety/depression and work and activities----[1] 13 💬
268Apitox - pure honeybee toxin----[1] 13 💬
269Apricot[1] Apricot---[1] 13 💬
270Apricot kernel oil[2] Apricot,
Apricot kernel oil		---[1] 13 💬
271Arbaclofen[1] Arbaclofen[1] Arbaclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[2] 13, 206 💬
272Arbaclofen ER Tablets[1] Arbaclofen[1] Arbaclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
273Arbaclofen Extended Release Tablets[1] Arbaclofen[1] Arbaclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
274Arbaclofen Placarbil[2] Arbaclofen,
Arbaclofen Placarbil		[2] Arbaclofen placarbil ,
Arbaclofen 💬 		[2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
275Arbaclofen placarbil 15 mg BID[2] Arbaclofen,
Arbaclofen Placarbil		[2] Arbaclofen placarbil ,
Arbaclofen 💬 		[2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
276Arbaclofen placarbil 30 mg BID[2] Arbaclofen,
Arbaclofen Placarbil		[2] Arbaclofen placarbil ,
Arbaclofen 💬 		[2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
277Arbaclofen placarbil 45 mg BID[2] Arbaclofen,
Arbaclofen Placarbil		[2] Arbaclofen placarbil ,
Arbaclofen 💬 		[2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
278ARICEPT----[3] 6, 13, 124 💬
279Aricept 10 mg----[1] 13 💬
280Aricept 10 mg filmdragerade tabletter----[1] 13 💬
281Aricept 5 mg----[1] 13 💬
282Aricept 5 mg filmdragerade tabletter----[1] 13 💬
283Arm 1 - GEH120714 (18F) Injection----[1] 13 💬
284Armodafinil[1] Armodafinil[1] Armodafinil 💬 [1] SLC6A3 💬 [8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[3] 6, 13, 84 💬
285ARN-6039----[1] 13 💬
286Arzerra----[3] 13, 222, 223 💬
287ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI----[2] 13, 222 💬
288ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA----[1] 13 💬
289ArzerraProduct Name: ofatumumabProduct Code: OMB157Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: OFATUMUMABCAS Number: 679818-59-8Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useTrade Name: KesimptaProduct Name: ofatumumabProduct Code: OMB157Pharmaceutical Form: Solution for injection in pre-filled penINN or Proposed INN: OFATUMUMABCAS Number: 679818-59-8Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-----[1] 13 💬
290Arzerra®----[1] 13 💬
291ASA----[1] 13 💬
292ASB-683699----[1] 13 💬
293Aspirin 650mg Oral Capsule----[1] 13 💬
294ATA188----[1] 13 💬
295Atacicept[1] Atacicept[1] Atacicept 💬 [2] TNFSF13,
TNFSF13B 💬 		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[5] 13, 46, 49, 66, 222 💬
296Atacicept 150 mg[1] Atacicept[1] Atacicept 💬 [2] TNFSF13,
TNFSF13B 💬 		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 13, 49, 66 💬
297Atacicept 25 mg[1] Atacicept[1] Atacicept 💬 [2] TNFSF13,
TNFSF13B 💬 		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 13, 66 💬
298Atacicept 75 mg[1] Atacicept[1] Atacicept 💬 [2] TNFSF13,
TNFSF13B 💬 		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 13, 49, 66 💬
299ATG----[6] 13, 19, 60, 96, 222, 285 💬
300ATL1102[1] ATL1102---[2] 13, 113 💬
301ATLG administration----[1] 13 💬
302Atomoxetine[1] Atomoxetine[2] Atomoxetine hydrochloride ,
Atomoxetine 💬 		[1] SLC6A2 💬 [2] Neuroactive ligand signaling, Synaptic vesicle cycle 💬[4] 6, 8, 13, 17 💬
303Atorvastatin[1] Atorvastatin[2] Atorvastatin calcium ,
Atorvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
304ATX-MS-1467----[1] 13 💬
305AUBAGIO----[1] 13 💬
306AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA----[1] 13 💬
307AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE----[1] 13 💬
308Aubagio 14 mg film-coated tablets----[1] 13 💬
309Aubagio 14MG TBL FLM----[1] 13 💬
310AubagioProduct Name: TeriflunomidePharmaceutical Form: Capsule, hardINN or Proposed INN: TERIFLUNOMIDECAS Number: 108605-62-5Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 14-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral use----[1] 13 💬
311AubagioProduct Name: TeriflunomideProduct Code: HMR1726Pharmaceutical Form: Film-coated tabletINN or Proposed INN: TERIFLUNOMIDECAS Number: 108605-62-5Current Sponsor code: HMR1726Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 14-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 13 💬
312Aubagio®----[1] 13 💬
313Autologous adipose derived mesenchymal cells----[1] 13 💬
314Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved----[1] 13 💬
315Autologous bone marrow transplantation----[2] 13, 28 💬
316Autologous Bone Marrow-Derived Mononuclear Stem Cells----[1] 13 💬
317Autologous CD19-BCMA Dual-Target CAR T-Cell Therapy----[5] 13, 49, 51, 53, 61 💬
318Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----[1] 13 💬
319Autologous HB-adMSCs----[1] 13 💬
320Autologous Hematopoietic Stem Cell----[1] 13 💬
321Autologous hematopoietic stem cell transplant----[1] 13 💬
322Autologous Hematopoietic Stem Cell Transplantation----[7] 11, 13, 14, 28, 49, 51, 84 💬
323Autologous hematopoietic stem cells----[1] 13 💬
324Autologous Mesenchymal Cell Product----[1] 13 💬
325Autologous mesenchymal stem cell transplantation----[1] 13 💬
326Autologous mesenchymal stem cells----[5] 2, 6, 13, 17, 46 💬
327Autologous myelin-derived peptide-pulsed tolerogenic dendritic cells----[1] 13 💬
328Autologous Stem Cell Transplantation----[4] 13, 28, 56, 96 💬
329Autologous Stem Cells----[2] 13, 51 💬
330AUTOLOGOUS T-LYMPHOCYTES----[1] 13 💬
331Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)----[1] 13 💬
332AV605----[1] 13 💬
333AVONEX----[2] 13, 97 💬
334Avonex (IFNbeta-1-a, Biogen Netherlands B.V)----[1] 13 💬
335Avonex (IFNß-1-a, Biogen Netherlands B.V)----[1] 13 💬
336Avonex (Interferon beta 1a)----[1] 13 💬
337Avonex (interferon beta-1a), Biogen Idec Ltd[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
338AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE----[1] 13 💬
339Avonex 30 microgram/0.5 ml Solution for Injection----[1] 13 💬
340AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable----[1] 13 💬
341Avonex 30 microgramos/0.5 ml Solución para inyección----[1] 13 💬
342AVONEX 30 µg/0,5 ml solution for injection----[1] 13 💬
343Avonex and Topamax----[1] 13 💬
344AVONEX IM 4SIR 30MCG/0,5ML 4AG----[1] 13 💬
345Avonex prefilled syringe via manual IM injection----[1] 13 💬
346AVONEX*IM 4SIR 30MCG/0,5ML+4AG----[1] 13 💬
347Avonex/Betaseron/Copaxone/Rebif----[1] 13 💬
348Avonex/Zocor----[1] 13 💬
349AVONEXPharmaceutical Form: Solution for injectionOther descriptive name: INTERFERON BETA-1AConcentration unit: µg microgram(s)Concentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Intramuscular use----[1] 13 💬
350AVONEX®----[1] 13 💬
351Avonex® monotherapy (6.0 MIU administered i.m. each week)----[1] 13 💬
352AVP-923----[3] 2, 6, 13 💬
353Azathioprine[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬 		--[26] 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
354Azathioprine (AZA)[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬 		--[5] 13, 19, 49, 55, 97 💬
355AZATIOPRINA HEX. 50CPR 50MG BL[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬 		--[1] 13 💬
356AZD0120 - Regimen 1----[1] 13 💬
357AZD0120 - Regimen 2----[1] 13 💬
358Azithromycin[1] Azithromycin[3] Azithromycin hydrate ,
Azithromycin ,
Azithromycin 💬 		--[8] 13, 84, 85, 96, 222, 228, 299, 340 💬
359B001----[1] 13 💬
360B001 injection----[1] 13 💬
361Bacille Calmette-Guerin vaccine----[1] 13 💬
362Bacille of Calmette-Guerin----[1] 13 💬
363Baclofen[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[8] 2, 10, 13, 18, 65, 70, 149, 206 💬
364Baclofen 20 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
365Baclofen ER Capsules (GRS) 10 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
366Baclofen ER Capsules (GRS) 20 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
367Baclofen ER Capsules (GRS) 30mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
368Baclofen ER Capsules (GRS) 40mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
369Baclofen ER Capsules (GRS) 50 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
370Baclofen IR[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
371Baclofen Tablets USP[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
372Baclofen Tablets USP 10 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
373BAF312----[2] 13, 50 💬
374BAF312 0,25 mg tablet----[1] 13 💬
375BAF312 1 mg tablet----[2] 13, 50 💬
376BAF312 4 mg tablet----[1] 13 💬
377BAF312 hemifumarate----[2] 13, 50 💬
378BAF312A----[1] 13 💬
379Bafiertam----[1] 13 💬
380Balance platform therapy----[1] 13 💬
381Baminercept[1] Baminercept[1] Baminercept 💬 [1] LTB 💬 [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 13, 46, 53, 97 💬
382Baricitinib[1] Baricitinib[1] Baricitinib 💬 [2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[24] 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
383Baseline disease modifying therapies (DMTs)----[1] 13 💬
384Baseline Treatment----[1] 13 💬
385BAT4406F----[2] 13, 222 💬
386BAT4406F Injection----[1] 13 💬
387BAY 79-4998----[1] 13 💬
388BAY86-5046----[1] 13 💬
389BAY86-5046_Interferon-beta-1b----[1] 13 💬
390Bazedoxifene[1] Bazedoxifene[1] Bazedoxifene acetate 💬 [2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
391Bazedoxifene Acetate[2] Acetate,
Bazedoxifene		[1] Bazedoxifene acetate 💬 [2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
392BBR 2778----[2] 11, 13 💬
393BCD-033 (interferon beta 1a)----[1] 13 💬
394BCD-054 180 mcg----[1] 13 💬
395BCD-054 240 mcg----[1] 13 💬
396BCD-063----[1] 13 💬
397BCD-132----[1] 13 💬
398BCD-132, 125 mg----[1] 13 💬
399BCD-132, 500 mg----[1] 13 💬
400BCG20-0134----[1] 13 💬
401BEAM Regimen----[1] 13 💬
402Beetainterferoni -1a----[1] 13 💬
403Behavioral: 6 months weight resistance and balance program----[1] 13 💬
404Behavioral: Adherence counseling----[1] 13 💬
405Behavioral: Assessment of disability----[1] 13 💬
406Behavioral: Assessment of impact of MS on cognition----[1] 13 💬
407Behavioral: Balance targeted exercises----[1] 13 💬
408Behavioral: Balance Training----[3] 6, 13, 18 💬
409Behavioral: Functional Balance Intervention----[1] 13 💬
410Behavioral: Home-based balance training----[1] 13 💬
411Behavioral: lavender oil[1] Lavender oil[1] Lavender oil 💬 --[1] 13 💬
412Behavioral: learning----[1] 13 💬
413Behavioral: Low Histamine-Based Modified Mediterranean Diet[1] Histamine[3] Histamine dihydrochloride ,
Histamine phosphate ,
Histamine 💬 		[4] HRH1,
HRH2,
HRH3,
HRH4 💬 		[5] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
414Behavioral: Medical Marijuana----[1] 13 💬
415Behavioral: meditation----[1] 13 💬
416Behavioral: MIND Diet (Mediterranean-DASH Intervention for Neurodegenerative Delay)----[1] 13 💬
417Behavioral: Modified Paleolithic Elimination diet----[1] 13 💬
418Behavioral: Motivational Interviewing----[1] 13 💬
419Behavioral: Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibular and dynamic balance.----[1] 13 💬
420Behavioral: Physical Therapy----[2] 6, 13 💬
421Behavioral: Quality of Life questionnaires----[2] 13, 97 💬
422Behavioral: self massage----[1] 13 💬
423Behavioral: Sleep quality and physical activity----[1] 13 💬
424Behavioral: Smoking----[1] 13 💬
425Behavioral: Step Tracking----[1] 13 💬
426Behavioral: stretching----[2] 6, 13 💬
427Behavioral: Telephone-based Cognitive Behavioral Therapy----[1] 13 💬
428Behavioral: Time Restricted Olive Oil Based (TROO) Ketogenic Diet[1] Olive oil[1] Olive oil 💬 --[1] 13 💬
429Behavioral: Traditional Balance Exercise Training (BAL-EX)----[1] 13 💬
430Behavioral: Traditional healthy nutrition program specific to Turkey[1] Turkey---[1] 13 💬
431Behavioral: Traditional Mediterranean Diet----[1] 13 💬
432Behavioral: Usual diet with Dietary Guidelines for Americans Diet information----[1] 13 💬
433Behavioral: Water Tracking[1] Water[1] Water 💬 --[1] 13 💬
434BELIMUMAB[1] Belimumab[1] Belimumab 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[17] 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
435Bendamustine[1] Bendamustine[3] Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--[6] 13, 28, 49, 50, 51, 61 💬
436Best Available Therapy (BAT)----[1] 13 💬
437Beta-1b interferoni----[1] 13 💬
438Beta-Alanine[2] Alanine,
beta-Alanine		[2] Alanine ,
beta-Alanine 💬 		--[1] 13 💬
439Beta-alanine supplementation[2] Alanine,
beta-Alanine		[2] Alanine ,
beta-Alanine 💬 		--[1] 13 💬
440Beta-Carotene----[1] 13 💬
441Beta-Interferon----[1] 13 💬
442BETACAROTENE----[1] 13 💬
443BETACONNECT----[1] 13 💬
444Betaconnect auto-injector----[1] 13 💬
445BETACONNECT auto-injector.----[1] 13 💬
446Betaconnect Autoinjector----[1] 13 💬
447BETACONNECT device----[1] 13 💬
448BETAFERON----[1] 13 💬
449BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML----[1] 13 💬
450BETAFERON 250 mcg----[1] 13 💬
451Betaferon 250 microgram/ml----[1] 13 💬
452Betaferon 250 microgram/ml, powder and solvent for solution for injection----[1] 13 💬
453Betaferon 250 microgram/mL, powder and solvent for solution for injection.----[1] 13 💬
454Betaferon 250 microgramos----[1] 13 💬
455Betaferon 250mcg----[1] 13 💬
456Betaferon 250µg----[1] 13 💬
457BETAFERON 500 mcg----[1] 13 💬
458Betaferon 500 µg----[1] 13 💬
459Betaferon 500mcg----[1] 13 💬
460Betaferon 500µg----[1] 13 💬
461BETAFERON SC 15F 0,25MG 15SIR----[1] 13 💬
462BETAFERON*15CONFEZ 0,25MG/ML+----[1] 13 💬
463Betaferon, BAY86-5046----[1] 13 💬
464Betaferon/Betaseron----[1] 13 💬
465Betaferon®----[1] 13 💬
466BETAFERON® (interferon beta-1b)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
467Betaseron----[1] 13 💬
468Betaseron (IFN-beta-1-b, BAY86-5046, Bayer AG)----[1] 13 💬
469Betaseron (IFN-ß-1-b, BAY86-5046, Bayer AG)----[1] 13 💬
470Betaseron (Interferon beta-1b, BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
471Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
472Bevacizumab[1] Bevacizumab[1] Bevacizumab 💬 [1] VEGFA 💬 [24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
473Bexarotene[1] Bexarotene[1] Bexarotene 💬 [3] RXRA,
RXRB,
RXRG 💬 		[18] Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬[2] 13, 75 💬
474Bexsero----[4] 11, 13, 62, 223 💬
475BG-12 120----[1] 13 💬
476BG00002----[1] 13 💬
477BG00002 (natalizumab)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
478BG00002-E (natalizumab high titer)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
479BG00012----[2] 13, 46 💬
480BG00012 (DMF)----[1] 13 💬
481BG00012 (DMF) (Tecfidera®.)----[1] 13 💬
482BG0002 (natalizumab)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
483BG9418----[1] 13 💬
484BG9418 (interferon beta 1-a)----[1] 13 💬
485BG9418 (interferon beta-1a)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[2] 13, 97 💬
486BGC20-0134----[1] 13 💬
487BGG492----[1] 13 💬
488BHT-3009----[1] 13 💬
489BHT-3009 0.5 mg----[1] 13 💬
490BHT-3009 1.5 mg----[1] 13 💬
491BHT-3009-01----[1] 13 💬
492Bifidobacterium longum[1] Bifidobacterium longum---[2] 13, 97 💬
493BIIB017----[1] 13 💬
494BIIB017 (Peginterferon beta-1a)[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
495BIIB017 (peginterferon beta-1a) Autoinjector[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
496BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
497BIIB019----[1] 13 💬
498BIIB019 (Daclizumab High Yield Process)[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
499BIIB019 (Daclizumab)[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
500BIIB033----[1] 13 💬
501BIIB033 (ANTI-LINGO)----[1] 13 💬
502BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957----[1] 13 💬
503BIIB033 (opicinumab)[1] Opicinumab[1] Opicinumab 💬 --[1] 13 💬
504BIIB041----[1] 13 💬
505BIIB041 (fampridine)----[1] 13 💬
506BIIB041 (Fampridine-SR)----[1] 13 💬
507BIIB041 (PR Fampridine)----[1] 13 💬
508BIIB061----[1] 13 💬
509BIIB091----[1] 13 💬
510BIIB133----[1] 13 💬
511Bioactivated GRA for adult patients----[2] 6, 13 💬
512Bioactivated GRA for pediatric patients----[2] 6, 13 💬
513Biological samples----[1] 13 💬
514Biospecimen Collection----[18] 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
515BIOTIN[1] Biotin[1] Biotin 💬 --[6] 2, 8, 10, 13, 14, 20 💬
516BIRT 2584 XX----[1] 13 💬
517BIRT 2584XX----[1] 13 💬
518Bisacodyl[1] Bisacodyl[1] Bisacodyl 💬 --[2] 13, 97 💬
519Blood draw----[16] 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
520Blood draw for the laboratory assessment----[2] 13, 303 💬
521Blood purification equipment----[1] 13 💬
522Blood sample----[33] 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
523Blood sample provided----[1] 13 💬
524Blood sample to analyse AMH level on the serum----[1] 13 💬
525Blood samples----[14] 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
526Blood sampling----[15] 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
527Blood test----[19] 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
528Blood testing----[1] 13 💬
529Blood withdrawal----[3] 13, 48, 65 💬
530BMMNC----[2] 13, 57 💬
531BMS 188667 (Abatacept)[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[1] 13 💬
532BMS-986368----[1] 13 💬
533BMS-986374----[1] 13 💬
534BNT162----[1] 13 💬
535BNT162b2----[7] 13, 35, 46, 49, 50, 51, 107 💬
536BNT162b2, Bivalent----[7] 13, 35, 46, 49, 50, 51, 107 💬
537BodyBio Balance Oil----[1] 13 💬
538BodyBio PC----[1] 13 💬
539Bone marrow autologous mesenchymal stem cells transplantation----[1] 13 💬
540BORAGE OIL[1] Borage oil---[1] 13 💬
541BORAGE OIL 20% GLA[1] Borage oil---[1] 13 💬
542BORTEZOMIB[1] Bortezomib[1] Bortezomib 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[19] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
543Bosentan[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
544BOSWELAN----[1] 13 💬
545Boswellia serrata extract PS0201Bo capsules----[1] 13 💬
546Boswellic acids (BOSWELAN)----[1] 13 💬
547BOTOX----[5] 6, 13, 36, 149, 226 💬
548Botox 100 UNT Injection----[1] 13 💬
549BOTOX®----[1] 13 💬
550Botulinum Toxin----[3] 6, 13, 149 💬
551Botulinum toxin A----[2] 13, 226 💬
552BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
553BOTULINUM TOXIN TYPE A[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[13] 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
554Botulinum Toxin Type A 200U[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
555Botulinum Toxin Type A 300U[1] Botulinum toxin type A[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
556Bouchard Belgian Dark Chocolate Probiotic Napolitains, containing bifidobacterium longum[1] Bifidobacterium longum---[1] 13 💬
557Brimonidine[1] Brimonidine[2] Brimonidine tartrate ,
Brimonidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
558Brimonidine tartrate[1] Brimonidine[2] Brimonidine tartrate ,
Brimonidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
559Bryostatin 1[1] Bryostatin 1---[2] 13, 62 💬
560BX-1----[1] 13 💬
561C-11 ER176 Radiotracer----[1] 13 💬
562C1-esterase inhibitor (Cinryze)----[1] 13 💬
563C105----[1] 13 💬
564C11 Pittsburgh Compound B[1] Pittsburgh Compound B---[1] 13 💬
565CABA-201----[5] 11, 13, 35, 49, 51 💬
566Cabozantinib[1] Cabozantinib[2] Cabozantinib ,
Cabozantinib s-malate 💬 		[3] AXL,
KDR,
MET 💬 		[28] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬[9] 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
567Caffeine[1] Caffeine[2] Caffeine ,
Caffeine citrate 💬 		[11] ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		[22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[8] 2, 6, 13, 21, 46, 96, 97, 265 💬
568CALCIO FOLINATO DC.IT[1] Calcium---[1] 13 💬
569Calcium[1] Calcium---[39] 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
570Calcium and Vitamin D combination[2] Calcium,
Vitamin D		---[1] 13 💬
571Calcium carbonate[2] Calcium,
Calcium carbonate		[2] Calcium carbonate ,
Calcium carbonate 💬 		--[10] 13, 19, 46, 53, 71, 75, 96, 97, 235, 299 💬
572Calcium levofolinate[1] Calcium---[1] 13 💬
573Calculus bovis sativus (CBS)----[1] 13 💬
574Cannabidiol[1] Cannabidiol[1] Cannabidiol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[20] 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
575Cannabidiol (CBD)[1] Cannabidiol[1] Cannabidiol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[7] 6, 13, 140, 144, 145, 156, 158 💬
576Cannabidiol / Dronabinol capsule 5 mg+2,5 mg[2] Cannabidiol,
Dronabinol		[2] Dronabinol ,
Cannabidiol 💬 		[2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
577Cannabidiol Botanical Drug Substance (CBD BDS)[1] Cannabidiol[1] Cannabidiol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
578Cannabidiol capsule 5 mg[1] Cannabidiol[1] Cannabidiol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
579Cannabis----[2] 13, 90 💬
580Cannabis Based Medicine Extract (Sativex)----[1] 13 💬
581Cannabis, Medical----[5] 2, 6, 13, 96, 97 💬
582Cannador----[1] 13 💬
583Capacity of muscular oxygen extraction[1] Oxygen[1] Oxygen 💬 --[1] 13 💬
584Caprylic Triglyceride----[1] 13 💬
585Capsules with 160 mg Teavigo (at least 94% EGCG)----[1] 13 💬
586CAR-T cells injection----[1] 13 💬
587Carbamazepine[1] Carbamazepine[1] Carbamazepine 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[6] 6, 13, 137, 145, 158, 231 💬
588CARBIDOPA[1] Carbidopa[1] Carbidopa 💬 [1] DDC 💬 [8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[7] 6, 13, 17, 90, 140, 164, 201 💬
589Carbon orthosis (control)----[1] 13 💬
590CARBONE VEGETALE----[1] 13 💬
591Carbone vegetale polvere----[1] 13 💬
592CARMUSTINA----[1] 13 💬
593Carmustine[1] Carmustine[1] Carmustine 💬 --[5] 11, 13, 14, 28, 60 💬
594Carmustine, etoposide, cytarabine, and melphalan (BEAM)[4] Carmustine,
Cytarabine,
Etoposide,
Melphalan		[7] Etoposide ,
Cytarabine ,
Carmustine ,
Melphalan ,
Cytarabine hydrochloride ,
Etoposide phosphate ,
Melphalan hydrochloride 💬 		--[1] 13 💬
595Carnosine[1] Carnosine---[2] 6, 13 💬
596Carnosine, capsulle, 2 g/day, 8 weeks[1] Carnosine---[1] 13 💬
597CBD----[2] 13, 36 💬
598CC-97540----[5] 11, 13, 46, 49, 51 💬
599CC-97540 (BMS-986353)----[1] 13 💬
600CCI-779----[2] 13, 46 💬
601CD19/BCMA-targeted CAR-T cells----[3] 11, 13, 14 💬
602CD20/BCMA-directed CAR-T cells----[4] 11, 13, 49, 51 💬
603CDP323[1] CDP323---[1] 13 💬
604CE211NS21----[1] 13 💬
605CELECOXIB[1] Celecoxib[1] Celecoxib 💬 [1] PTGS2 💬 [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[14] 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
606Cell suspension containing dendritic cells----[1] 13 💬
607CELLCEPT----[7] 11, 13, 42, 43, 49, 222, 223 💬
608Cellular therapy with EBV specific autologous CTL infusion----[1] 13 💬
609Ceralifimod[1] Ceralifimod---[1] 13 💬
610Ceralifmod----[1] 13 💬
611Cerebro-spinal fluid----[1] 13 💬
612Cesamet™ (nabilone)[1] Nabilone[1] Nabilone 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
613Ceterizine----[1] 13 💬
614Cetirizina[1] Cetirizine[2] Cetirizine hydrochloride ,
Cetirizine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[3] 13, 300, 309 💬
615Cetirizina Mylan Generics[1] Cetirizine[2] Cetirizine hydrochloride ,
Cetirizine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
616Cetirizine[1] Cetirizine[2] Cetirizine hydrochloride ,
Cetirizine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[3] 13, 19, 35 💬
617CETIRIZINE HYDROCHLORIDE[1] Cetirizine[2] Cetirizine hydrochloride ,
Cetirizine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
618Cetrizine----[1] 13 💬
619CGP 77116----[1] 13 💬
620Charcoal----[1] 13 💬
621Chemotherapy: cyclophosphamide (CYC)[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 13 💬
622Chemotherapy: fludarabine (FLU)[1] Fludarabine[2] Fludarabine phosphate ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
623CHOLECALCIFEROL[1] Cholecalciferol[1] Cholecalciferol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[10] 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
624Cholecalciferol (Vitamin D3)[1] Cholecalciferol[1] Cholecalciferol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[2] 13, 299 💬
625Cholecalciferol, Vitamin D3[1] Cholecalciferol[1] Cholecalciferol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 13 💬
626Cholestyramine[1] Cholestyramine[1] Cholestyramine resin 💬 --[2] 13, 79 💬
627CHR-1103 / GBR500----[1] 13 💬
628CIANOCOBALAMINA FU DC.IT----[1] 13 💬
629CIC using LoFric Primo----[1] 13 💬
630Cilostazol[1] Cilostazol[1] Cilostazol 💬 [3] PDE3A,
PDE3B,
TBXA2R 💬 		[13] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[7] 6, 13, 46, 48, 51, 70, 124 💬
631Circadin----[1] 13 💬
632Circadin ( INN= Melatonin)[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 13 💬
633CISAPRIDE[1] Cisapride[2] Cisapride ,
Cisapride 💬 		[3] HTR2A,
HTR3A,
HTR4 💬 		[8] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
634Citalopram[1] Citalopram[2] Citalopram hydrobromide ,
Citalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[7] 6, 8, 13, 18, 46, 98, 127 💬
635CITARABINA----[1] 13 💬
636CITOCHINE ED IMMUNOMODULATORI----[1] 13 💬
637CLADRIBINA[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
638Cladribina oral[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
639CLADRIBINE[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[3] 11, 13, 94 💬
640Cladribine (MAVENCLAD®)[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
641Cladribine 10 mg oral tablet[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
642Cladribine 3.5 mg/kg[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
643Cladribine 5.25 mg/kg[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
644Cladribine Oral Tablet[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
645Cladribine Pill[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
646Cladribine Subcutaneous Injection[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
647Cladribine Tablet[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
648Cladribine Tablets[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
649Clemastine[1] Clemastine[2] Clemastine fumarate ,
Clemastine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[2] 13, 179 💬
650CLEMASTINE FUMARATE[1] Clemastine[2] Clemastine fumarate ,
Clemastine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
651Clemastine Milstein 1 mg, tabletten[1] Clemastine[2] Clemastine fumarate ,
Clemastine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
652Clinican CBD 10% oil----[1] 13 💬
653Clostridium botulinum[1] Clostridium botulinum---[1] 13 💬
654CLOSTRIDIUM BOTULINUM TOXIN TYPE A[2] Botulinum toxin type A,
Clostridium botulinum		[4] Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
655CLS12311----[1] 13 💬
656CLS12311 high----[1] 13 💬
657CLS12311 low----[1] 13 💬
658CLS12311 medium----[1] 13 💬
659CLS12311Pharmaceutical Form: Dispersion for infusionINN or Proposed INN: not applicableCurrent Sponsor code: CLS12311Other descriptive name: Peptid coupled red blood cellsConcentration unit: OtherConcentration type: rangeConcentration number: 2.2E11-3.5E11Pharmaceutical form of the placebo: InfusionRoute of administration of the placebo: Intravenous use----[1] 13 💬
660CNM-Au8[1] CNM-Au8---[2] 2, 13 💬
661Cnp-MS-0601----[1] 13 💬
662CNTO 1275----[2] 13, 96 💬
663CO-14----[1] 13 💬
664Coconut[1] Coconut---[2] 13, 53 💬
665Coconut oil[2] Coconut,
Coconut oil		[1] Coconut oil 💬 --[1] 13 💬
666Coconut oil and epigallocatechin gallate[4] Coconut,
Coconut oil,
Epigallocatechin,
Epigallocatechin gallate		[1] Coconut oil 💬 --[1] 13 💬
667Coenzyme Q----[1] 13 💬
668COLECALCIFEROL[1] Cholecalciferol[1] Cholecalciferol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[4] 13, 46, 96, 228 💬
669COLECALCIFEROL CONCENTRATE (OILY FORM)----[1] 13 💬
670COLESTIRAMINA----[1] 13 💬
671Combination Product: ofatumumab with AI[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
672Combination Product: ofatumumab with PRF[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
673Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion----[1] 13 💬
674Companion blood samples with procedure----[4] 13, 51, 97, 271 💬
675Complement protein C5 inhibitor----[1] 13 💬
676Conjugated linoleic acid (CLA/Tonalin® FFA 80)[1] Linoleic acid---[1] 13 💬
677Continue IS (B cell depletion therapy)----[7] 13, 35, 46, 49, 50, 51, 107 💬
678Continue IS (MMF or MPA)----[7] 13, 35, 46, 49, 50, 51, 107 💬
679Continue IS (MTX)----[7] 13, 35, 46, 49, 50, 51, 107 💬
680Continued Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
681Control group----[6] 2, 13, 46, 70, 235, 240 💬
682COP-1/Copolymer-1[1] Glatiramer[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
683COPAXONE----[1] 13 💬
684COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE----[1] 13 💬
685COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE----[1] 13 💬
686COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN----[1] 13 💬
687COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO----[1] 13 💬
688Copaxone 20 mg----[1] 13 💬
689Copaxone 20 mg/ml----[1] 13 💬
690COPAXONE 20 mg/ml solución inyectable en jeringa precargada----[1] 13 💬
691Copaxone 20 mg/ml solución para inyección en jeringa precargada----[1] 13 💬
692Copaxone 20 mg/ml Solution for Injection, pre-filled syringe----[1] 13 💬
693Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes----[1] 13 💬
694Copaxone 20mg/ml Solution for Injection, pre-filled syringe----[1] 13 💬
695Copaxone 40 mg/ml----[1] 13 💬
696Copaxone 40 mg/ml solution for injection, pre-filled syringe----[1] 13 💬
697COPAXONE*SC 28SIR 20MG/ML----[1] 13 💬
698Copaxone-Teva----[1] 13 💬
699Copaxone®----[1] 13 💬
700Copolymer 1----[1] 13 💬
701Corticosteroid----[12] 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
702Corticosteroids & tanCART19/20----[1] 13 💬
703Corticotropin[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[10] 2, 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
704COVID-19 mRNA Vaccine (nucleoside modified)----[3] 13, 46, 51 💬
705COVID-19 mRNA vaccine (nucleoside-modified)----[4] 13, 46, 51, 299 💬
706COVID-19 mRNA vaccine Moderna (CX-024414)----[4] 13, 46, 51, 299 💬
707COVID-19 vaccination----[1] 13 💬
708COVID19 vaccine----[1] 13 💬
709Cranberry[1] Cranberry---[2] 13, 96 💬
710Creatine[1] Creatine---[18] 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
711Crefmirlimab[1] Crefmirlimab---[4] 13, 25, 51, 53 💬
712Crisugabalin[1] Crisugabalin---[2] 6, 13 💬
713Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells----[1] 13 💬
714CS-0777 tablets----[1] 13 💬
715CSF collection by lumbar puncture (Optional)----[1] 13 💬
716CSF sampling----[1] 13 💬
717CT-P53----[1] 13 💬
718CT103A[1] CT103A---[4] 11, 13, 14, 16 💬
719CT103A cells[1] CT103A---[4] 11, 13, 14, 16 💬
720Curcumin[1] Curcumin---[12] 2, 13, 34, 36, 46, 67, 74, 94, 96, 97, 139, 299 💬
721CYB704----[1] 13 💬
722Cyclophosfamide----[1] 13 💬
723Cyclophosphamide[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[50] 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
724Cyclophosphamide (drug)[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 13 💬
725Cyclophosphamide and ATG[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 13 💬
726Cyclophosphamide and fludarabine[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[4] 11, 13, 14, 16 💬
727CYCLOPHOSPHAMIDE MONOHYDRATE[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[4] 13, 60, 96, 256 💬
728Cyclophosphamide/ATG[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 13 💬
729Cyclophosphamide/Glatiramer acetate[3] Acetate,
Cyclophosphamide,
Glatiramer		[3] Cyclophosphamide ,
Glatiramer acetate ,
Cyclophosphamide 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
730Cyclophosphamide/Rituximab[2] Cyclophosphamide,
Rituximab		[3] Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
731CYMBALTA----[3] 6, 13, 49 💬
732Cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬 		--[13] 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
733Cytarabine[1] Cytarabine[2] Cytarabine ,
Cytarabine hydrochloride 💬 		--[8] 11, 13, 14, 25, 34, 49, 60, 65 💬
734Cytolytic CD4+ T cells----[1] 13 💬
735Cápsulas de Laquinimod 0.6 mg[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
736Células madre mesenquimales----[1] 13 💬
737D Mannose[1] Mannose[1] Demannose 💬 --[1] 13 💬
738D-aspartate----[1] 13 💬
739D-BIOTIN[1] Biotin[1] Biotin 💬 --[4] 10, 13, 14, 20 💬
740D-BIOTINA[1] Biotin[1] Biotin 💬 --[1] 13 💬
741DAC HYP----[1] 13 💬
742DAC-HYP----[1] 13 💬
743DACLIZUMAB[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[10] 13, 26, 56, 60, 63, 65, 97, 107, 283, 284 💬
744Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
745Daclizumab High Yield Process[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
746DACLIZUMAB HYP[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
747Daclizumab HYP (DAC HYP[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
748Daclizumab HYP (DAC HYP)[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
749DACLIZUMAB HYPProduct Code: BIIB019Pharmaceutical Form: Solution for injectionINN or Proposed INN: Daclizumab wih Greek suffixCurrent Sponsor code: BIIB019Other descriptive name: Daclizumab HYP (DAC HYP)Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
750Daclizumab with Greek suufix[1] Daclizumab[1] Daclizumab 💬 [1] IL2RA 💬 [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
751Dalfampridine[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 4, 13 💬
752Dalfampridine 10 MG [Ampyra][1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
753Dalfampridine ER[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
754Dalfampridine ER, 10 Mg Oral Tablet, Extended Release[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
755Dalfampridine-ER 10mg[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
756Dalfampridine-ER 5mg[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
757Dantrolene[1] Dantrolene[2] Dantrolene sodium ,
Dantrolene 💬 		--[2] 13, 233 💬
758DAPIROLIZUMAB PEGOL[1] Dapirolizumab pegol---[2] 13, 49 💬
759Daratumumab[1] Daratumumab[1] Daratumumab 💬 [1] CD38 💬 [6] Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[13] 13, 16, 28, 39, 46, 48, 49, 60, 63, 222, 223, 288, 331 💬
760Darifenacin[1] Darifenacin[2] Darifenacin hydrobromide ,
Darifenacin 💬 		[1] CHRM3 💬 [12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[4] 2, 6, 13, 26 💬
761Darifenacin (BAY79-4998)[1] Darifenacin[2] Darifenacin hydrobromide ,
Darifenacin 💬 		[1] CHRM3 💬 [12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[1] 13 💬
762Dasatinib[1] Dasatinib[2] Dasatinib ,
Dasatinib 💬 		[8] ABL1,
EPHA2,
FYN,
KIT,
LCK,
PDGFRB,
SRC,
YES1 💬 		[79] Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[3] 13, 51, 85 💬
763Dasatinib and quercetin[2] Dasatinib,
Quercetin		[2] Dasatinib ,
Dasatinib 💬 		[8] ABL1,
EPHA2,
FYN,
KIT,
LCK,
PDGFRB,
SRC,
YES1 💬 		[79] Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[1] 13 💬
764DC-TAB----[1] 13 💬
765Dekristol----[2] 13, 97 💬
766Dekristol 20000 IE----[1] 13 💬
767Dekristol® 400-Tabletten----[1] 13 💬
768Dekristol®-Tablette 1 (400 IE)----[1] 13 💬
769DELTA-9-TETRAHYDROCANNABINOL----[2] 13, 36 💬
770DEMESTRIL SEPTEM----[1] 13 💬
771Desloratadine[1] Desloratadine[1] Desloratadine 💬 [1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[3] 13, 46, 97 💬
772Desloratadine given orally[1] Desloratadine[1] Desloratadine 💬 [1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
773Device: Active stimulation----[1] 13 💬
774Device: Non-active stimulation----[1] 13 💬
775Dexamethason[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[4] 13, 28, 46, 331 💬
776Dexamethasone[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[29] 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
777Dexamethasone given orally[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
778Dexamethasone soduim phosphate[1] Dexamethasone[3] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
779Dexchlorpheniramine[1] Dexchlorpheniramine[1] Dexchlorpheniramine 💬 [1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[2] 13, 49 💬
780Dexrazoxane[1] Dexrazoxane[2] Dexrazoxane ,
Dexrazoxane hydrochloride 💬 		--[1] 13 💬
781Dexrazoxane (DRZ) plus Mitoxantrone (MX)[2] Dexrazoxane,
Mitoxantrone		[4] Mitoxantrone hydrochloride ,
Dexrazoxane ,
Dexrazoxane hydrochloride ,
Mitoxantrone 💬 		--[1] 13 💬
782Dextromethorphan[1] Dextromethorphan[3] Dextromethorphan hydrobromide ,
Dextromethorphan ,
Dextromethorphan polistirex 💬 		[6] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[10] 2, 6, 8, 13, 21, 46, 85, 96, 97, 156 💬
783DEXTROMETHORPHAN HYDROBROMIDE[1] Dextromethorphan[3] Dextromethorphan hydrobromide ,
Dextromethorphan ,
Dextromethorphan polistirex 💬 		[6] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[2] 13, 46 💬
784Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg[2] Dextromethorphan,
Quinidine		[7] Quinidine gluconate ,
Quinidine polygalacturonate ,
Dextromethorphan hydrobromide ,
Quinidine sulfate ,
Dextromethorphan ,
Dextromethorphan polistirex ,
Quinidine 💬 		[12] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A,
SIGMAR1 💬 		[25] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬[2] 2, 13 💬
785Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg[2] Dextromethorphan,
Quinidine		[7] Quinidine gluconate ,
Quinidine polygalacturonate ,
Dextromethorphan hydrobromide ,
Quinidine sulfate ,
Dextromethorphan ,
Dextromethorphan polistirex ,
Quinidine 💬 		[12] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A,
SIGMAR1 💬 		[25] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬[2] 2, 13 💬
786Dextromethorphan/Quinidine[2] Dextromethorphan,
Quinidine		[7] Quinidine gluconate ,
Quinidine polygalacturonate ,
Dextromethorphan hydrobromide ,
Quinidine sulfate ,
Dextromethorphan ,
Dextromethorphan polistirex ,
Quinidine 💬 		[12] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A,
SIGMAR1 💬 		[25] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
787DEXTROMETORFANO HIDROBROMURO----[1] 13 💬
788Dextrometorfano/Quinidina----[1] 13 💬
789Diagnostic Test: 7-T MRI scan----[1] 13 💬
790Diagnostic Test: anti-aquaporin-4 antibody----[1] 13 💬
791Diagnostic Test: anti-myelin oligodendrocyte glycoprotein----[1] 13 💬
792Diagnostic Test: Blood sample----[7] 10, 13, 49, 85, 271, 298, 299 💬
793Diagnostic Test: Blood sample collection for coagulation profile----[1] 13 💬
794Diagnostic Test: Blood samples and processing----[1] 13 💬
795Diagnostic Test: Blood samples for sNfL and sGFAP levels----[1] 13 💬
796Diagnostic Test: Blood test - EBV serology----[1] 13 💬
797Diagnostic Test: Blood test - Neurofilament light chain (NfL)----[1] 13 💬
798Diagnostic Test: blood tests drawn days 1, 8, 22 and 90 of the study----[1] 13 💬
799Diagnostic Test: Cerebrospinal and Blood Serum Semaphorin 4A Levels----[1] 13 💬
800Diagnostic Test: Entire-body PET-CT scans----[1] 13 💬
801Diagnostic Test: MRI----[3] 13, 51, 127 💬
802Diagnostic Test: MRI Brain and Cervical Spine----[1] 13 💬
803Diagnostic Test: Nicotine and cotinine serum levels[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[1] 13 💬
804Diagnostic Test: Oral Glucose Tolerance Test----[6] 6, 13, 57, 65, 77, 299 💬
805Diagnostic Test: PET with [11C]Flumazenil[1] Flumazenil[1] Flumazenil 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13 💬
806Diagnostic Test: PET/CT scan----[1] 13 💬
807Diagnostic Test: Stroop test----[1] 13 💬
808Diagnostic Test: Testing of autonomous nervous system function----[1] 13 💬
809Diazoxide[1] Diazoxide[2] Diazoxide ,
Diazoxide choline 💬 		[2] ABCC8,
KCNJ11 💬 		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[2] 13, 193 💬
810DIBASE----[1] 13 💬
811Diclofenac[1] Diclofenac[5] Diclofenac potassium ,
Diclofenac sodium ,
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[5] 13, 34, 46, 78, 271 💬
812Diclofenac sodium topical gel[1] Diclofenac[5] Diclofenac potassium ,
Diclofenac sodium ,
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
813Dietary Supplement: vitamin A[1] Vitamin A[2] Vitamin A oil ,
Vitamin A 💬 		[2] RARA,
RARB 💬 		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[1] 13 💬
814DIMETHYL FUMARATE[1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[5] 13, 20, 51, 86, 296 💬
815Dimethyl Fumarate (DMF)[1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[3] 13, 51, 86 💬
816Dimethyl fumarate 240 mg[1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[1] 13 💬
817Dimethyl Fumarate 240 MG [Tecfidera][1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[1] 13 💬
818Dimethyl fumarate [DMF][1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[1] 13 💬
819Dimethyl Fumarate Enteric-coated Capsules[1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[1] 13 💬
820DIMETIL-FUMARATO----[1] 13 💬
821Dimetilfumarato----[1] 13 💬
822Diphenhydramine[1] Diphenhydramine[4] Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[12] 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
823Diphenhydramine IV[1] Diphenhydramine[4] Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
824Diphenydramine----[1] 13 💬
825Diroximel Fumarate[1] Diroximel fumarate[1] Diroximel fumarate 💬 --[1] 13 💬
826Diroximel Fumarate (DRF)[1] Diroximel fumarate[1] Diroximel fumarate 💬 --[1] 13 💬
827Dirucotide[1] Dirucotide[1] Dirucotide 💬 --[1] 13 💬
828Dirucotide acetate[2] Acetate,
Dirucotide		[1] Dirucotide 💬 --[1] 13 💬
829Discontinuation of disease modifying therapy----[1] 13 💬
830Disease Modifying therapy----[1] 13 💬
831Disease modifying treatment (DMT)----[1] 13 💬
832Disease-Modifying Therapies (DMTs)----[1] 13 💬
833Divozilimab[1] Divozilimab[1] Divozilimab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 13, 49, 51 💬
834DMT----[1] 13 💬
835DMT continuation----[1] 13 💬
836DMTs----[1] 13 💬
837DMTs + taurine[1] Taurine[1] Taurine 💬 --[1] 13 💬
838Docosahexaenoic Acid (DHA) Dietary Supplement----[2] 13, 301 💬
839Domperidone[1] Domperidone[2] Domperidone ,
Domperidone maleate 💬 		[1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[5] 6, 13, 17, 51, 230 💬
840Donepezil[1] Donepezil[2] Donepezil hydrochloride ,
Donepezil 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[8] 5, 6, 13, 46, 124, 127, 156, 206 💬
841Donepezil HCI (drug)[1] Donepezil[2] Donepezil hydrochloride ,
Donepezil 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 13 💬
842Dosing Interruption of Natalizumab[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
843Dotarem 0,5mmol/ml,----[1] 13 💬
844Doxycycline[1] Doxycycline[5] Doxycycline ,
Doxycycline hyclate ,
Doxycycline calcium ,
Doxycycline ,
Doxycycline hydrochloride 💬 		--[17] 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
845DPA-714 PET/MRI----[1] 13 💬
846DRF----[1] 13 💬
847Dronabinol[1] Dronabinol[1] Dronabinol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[5] 2, 13, 46, 271, 298 💬
848Dronabinol 25 mg/ml, oral drops[1] Dronabinol[1] Dronabinol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
849Dronabinol capsule 2,5 mg[1] Dronabinol[1] Dronabinol 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13 💬
850Drug - SHR1459----[1] 13 💬
851Duloxetine[1] Duloxetine[2] Duloxetine hydrochloride ,
Duloxetine 💬 		[2] SLC6A2,
SLC6A4 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[3] 6, 13, 97 💬
852Duloxetine Hydrochloride (HCI)[1] Duloxetine[2] Duloxetine hydrochloride ,
Duloxetine 💬 		[2] SLC6A2,
SLC6A4 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13 💬
853DUOC-01----[3] 13, 19, 20 💬
854DYDROGESTERONE[1] Dydrogesterone[1] Dydrogesterone 💬 [1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
855Dynamic Contrast-Enhanced Magnetic Resonance Imaging----[1] 13 💬
856Dysport----[2] 13, 36 💬
857DYSPORT*SC IM 2FL 500U----[1] 13 💬
858DYSPORT®----[1] 13 💬
859Early Harvest Extra Virgin Olive Oil[1] Olive oil[1] Olive oil 💬 --[1] 13 💬
860Early Highly Effective Therapies Group----[1] 13 💬
861EBIXA----[3] 2, 6, 13 💬
862ECP002A----[1] 13 💬
863ECULIZUMAB[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 11, 13, 14, 61, 62, 109, 221, 223 💬
864Eculizumab (Soliris®)[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 13 💬
865Eculizumab administration[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 13 💬
866Eculizumab+IVMP[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 13 💬
867EFALIZUMAB[1] Efalizumab[1] Efalizumab 💬 [1] ITGAL 💬 [14] Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬[10] 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬
868EFGARTIGIMOD ALFA[1] Efgartigimod alfa[1] Efgartigimod alfa 💬 --[7] 11, 13, 14, 35, 53, 63, 162 💬
869Efgartigimod Alfa Injection[1] Efgartigimod alfa[1] Efgartigimod alfa 💬 --[1] 13 💬
870EGb 761® (Tanakan®)----[1] 13 💬
871EHP-101 25 mg BID----[1] 13 💬
872EHP-101 25 mg OD----[1] 13 💬
873EHP-101 50 mg BID----[1] 13 💬
874EHP-101 50 mg OD----[1] 13 💬
875EK-12----[1] 13 💬
876Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test----[1] 13 💬
877Elezanumab[1] Elezanumab[1] Elezanumab 💬 [1] RGMA 💬 [2] Axon guidance, TGF-beta signaling pathway 💬[1] 13 💬
878ELND002----[1] 13 💬
879EMD 28162----[1] 13 💬
880EMSELEX 15 mg Retardtabletten----[1] 13 💬
881EMSELEX 7,5 mg Retardtabletten----[1] 13 💬
882Emtricitabine[1] Emtricitabine[1] Emtricitabine 💬 --[5] 13, 25, 93, 265, 325 💬
883ENA713----[2] 6, 13 💬
884Enalapril[1] Enalapril[2] Enalapril maleate ,
Enalapril 💬 		[1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬
885Encapsulated Baclofen 20 mg[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 13 💬
886Encapsulated Simvastatin tablets[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
887ENDOXAN----[6] 13, 28, 49, 51, 85, 162 💬
888Endoxan - ciclofosfamide----[1] 13 💬
889ENDOXAN BAXTER----[3] 13, 43, 96 💬
890Enspryng----[1] 13 💬
891EPARMEFOLIN 30 CPR 0,1/0,5MG----[1] 13 💬
892Epigallocatechin[1] Epigallocatechin---[5] 8, 13, 28, 85, 113 💬
893Epigallocatechin gallate[2] Epigallocatechin,
Epigallocatechin gallate		---[1] 13 💬
894Epigallocatechin-gallate (Sunphenon)[1] Epigallocatechin---[1] 13 💬
895EPO----[1] 13 💬
896Epoetin alfa----[3] 13, 18, 46 💬
897Epoetin beta[2] Epoetin beta,
Erythropoietin		[5] Epoetin alfa ,
Epoetin beta ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 13 💬
898Eritrociti accoppiati a peptidi----[1] 13 💬
899Erypo/Erypo FS----[1] 13 💬
900ERYTHROPOIETIN[1] Erythropoietin[4] Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[11] 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
901Escalation Therapies Group----[1] 13 💬
902Escitalopram[1] Escitalopram[2] Escitalopram oxalate ,
Escitalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[5] 2, 6, 13, 46, 77 💬
903Escitalopram oxalate antidepressant[1] Escitalopram[2] Escitalopram oxalate ,
Escitalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13 💬
904Esomeprazole[1] Esomeprazole[5] Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[10] 6, 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
905Essential - hydroxytyrosol[1] Hydroxytyrosol---[1] 13 💬
906Essential fatty acids----[1] 13 💬
907Estradiol[1] Estradiol[2] Estradiol ,
Estradiol hemihydrate 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[9] 13, 46, 49, 65, 76, 78, 118, 226, 299 💬
908ESTRADIOL HEMIHYDRATE[1] Estradiol[2] Estradiol ,
Estradiol hemihydrate 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
909Estriol[1] Estriol[2] Estriol ,
Estriol tripropionate 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[2] 13, 227 💬
910Estroprogestins----[1] 13 💬
911Eszopiclone[1] Eszopiclone[1] Eszopiclone 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[3] 6, 13, 46 💬
912ETHINYLESTRADIOL[1] Ethinylestradiol[1] Ethinyl estradiol 💬 [1] ESR1 💬 [9] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[2] 13, 118 💬
913Etifoxine[1] Etifoxine[2] Etifoxine ,
Etifoxine hydrochloride 💬 		--[1] 13 💬
914ETIMS----[1] 13 💬
915ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)----[1] 13 💬
916Etoposide[1] Etoposide[2] Etoposide ,
Etoposide phosphate 💬 		--[12] 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
917EU-Ocrevus----[1] 13 💬
918EU/1/08/454/001-002, EU/1/08/454/005-007----[1] 13 💬
919EU/1/95/003/005-010----[1] 13 💬
920EU/1/97/033/002----[1] 13 💬
921EU/1/98/063/001-003----[1] 13 💬
922EU/1/98/063/004-006----[1] 13 💬
923EVOBRUTINIB[1] Evobrutinib[1] Evobrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[3] 13, 46, 49 💬
924Evobrutinib 10mg[1] Evobrutinib[1] Evobrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬
925Evobrutinib 25mg[1] Evobrutinib[1] Evobrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬
926EXELON----[2] 6, 13 💬
927Exelon transdermales Pflaster----[1] 13 💬
928Exergame----[2] 6, 13 💬
929Experimental Glatiramer Acetate[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
930Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS----[1] 13 💬
931EXTAVIA----[1] 13 💬
932Extavia (IFNbeta-1-b, Novartis Europharm Limited)----[1] 13 💬
933Extavia (IFNß-1-b, Novartis Europharm Limited)----[1] 13 💬
934Extavia (interferon beta-1b), Novartis Pharma AG[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
935Extavia 250 microgram/ml----[1] 13 💬
936Extavia 250 micrograms/ml----[1] 13 💬
937EXTAVIA*SC 15FL 250MCG/ML+15SI----[1] 13 💬
938Extavia®----[1] 13 💬
939Extended release fampridine----[1] 13 💬
940Extended-release oxycodone[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
941Extended-release quetiapine fumarate[1] Quetiapine[2] Quetiapine fumarate ,
Quetiapine 💬 		[2] DRD2,
HTR2A 💬 		[13] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬[1] 13 💬
942Extracellular vesicles derived from human-induced neural stem cells for intrathecal injection----[1] 13 💬
943Extracorporeal Photopheresis----[3] 13, 46, 96 💬
944F-18 3F4AP----[1] 13 💬
945F-18 FEDAA1106 (BAY85-8101)----[1] 13 💬
946Famciclovir[1] Famciclovir[1] Famciclovir 💬 --[2] 11, 13 💬
947FAMPRIDINA----[1] 13 💬
948FAMPRIDINE----[2] 13, 14 💬
949Fampridine SR----[1] 13 💬
950Fampridine-SR----[1] 13 💬
951Fampridine-SR b.i.d. (Twice Daily)----[1] 13 💬
952FAMPYRA----[2] 13, 14 💬
953FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)----[1] 13 💬
954Fampyra 10 mg prolonged-release tablets----[1] 13 💬
955Fampyra 10mg prolonged release tablets----[1] 13 💬
956Fatigue----[1] 13 💬
957Febuxostat[1] Febuxostat[2] Febuxostat ,
Febuxostat hydrate 💬 		[1] XDH 💬 [4] Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬[5] 2, 6, 13, 67, 97 💬
958Fecal microbial transplant (FMT)----[1] 13 💬
959Fecal Microbial Transplants----[1] 13 💬
960Fecal microbiota[1] Fecal microbiota---[14] 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
961Fecal microbiota transplantation[1] Fecal microbiota---[9] 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
962Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool[1] Fecal microbiota---[1] 13 💬
963Femoston 1/10----[1] 13 💬
964Femoston 2/10----[1] 13 💬
965FENEBRUTINIB[1] Fenebrutinib[1] Fenebrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬
966FenebrutinibProduct Code: RO7010939Pharmaceutical Form: Film-coated tabletINN or Proposed INN: FENEBRUTINIBCurrent Sponsor code: RO7010939Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 100-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 13 💬
967Feraheme----[1] 13 💬
968Ferumoxytol[1] Ferumoxytol[1] Ferumoxytol 💬 --[2] 13, 226 💬
969Ferumoxytol infusion[1] Ferumoxytol[1] Ferumoxytol 💬 --[1] 13 💬
970Fexofenadine[1] Fexofenadine[2] Fexofenadine hydrochloride ,
Fexofenadine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[4] 6, 13, 19, 46 💬
971Filgrastim[1] Filgrastim[1] Filgrastim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[30] 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
972Fingolimob----[1] 13 💬
973Fingolimob (FTY)----[1] 13 💬
974FINGOLIMOD[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 14, 156 💬
975Fingolimod (FTY720)[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 156 💬
976Fingolimod 0.5 mg[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
977Fingolimod 0.5mg[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
978Fingolimod 1.25 mg[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
979FINGOLIMOD HYDROCHLORIDE[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14 💬
980Fingolimodi----[1] 13 💬
981Fingolmod----[1] 13 💬
982Firategrast[1] Firategrast[1] Firategrast 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
983Firategrast (USAN approved name)[1] Firategrast[1] Firategrast 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
984Firategrast 150 mg[1] Firategrast[1] Firategrast 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
985Firategrast 300 mg[1] Firategrast[1] Firategrast 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
986Firategrast gastro-retentive solution[1] Firategrast[1] Firategrast 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
987Firategrast immediate release tablet[1] Firategrast[1] Firategrast 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
988Firategrast modified release tablet[1] Firategrast[1] Firategrast 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
989First line DMT----[1] 13 💬
990Fish Oil[1] Fish oil---[10] 13, 46, 49, 50, 66, 79, 96, 260, 294, 299 💬
991Fish oil concentrate[1] Fish oil---[1] 13 💬
992FISH OIL, RICH IN OMEGA-3-ACIDS[1] Fish oil---[1] 13 💬
993FISH OIL,RICH IN OMEGA 3 ACIDS[1] Fish oil---[1] 13 💬
994FLUDARA----[1] 13 💬
995Fludarabine[1] Fludarabine[2] Fludarabine phosphate ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[30] 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
996Fludarabine Phosphate for Injection[1] Fludarabine[2] Fludarabine phosphate ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
997Flumazenil[1] Flumazenil[1] Flumazenil 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[5] 6, 13, 17, 18, 206 💬
998Fluoropyrimidine----[8] 13, 46, 49, 50, 51, 53, 96, 97 💬
999Fluoxetin Hexal[1] Fluoxetine[2] Fluoxetine ,
Fluoxetine hydrochloride 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13 💬
1000FLUOXETINE[1] Fluoxetine[2] Fluoxetine ,
Fluoxetine hydrochloride 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[3] 13, 17, 86 💬
1001FLUOXETINE HYDROCHLORIDE[1] Fluoxetine[2] Fluoxetine ,
Fluoxetine hydrochloride 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13 💬
1002Flupirtin----[1] 13 💬
1003Flupirtine[1] Flupirtine[2] Flupirtine maleate ,
Flupirtine 💬 		--[1] 13 💬
1004Flupirtinmaleat----[1] 13 💬
1005FLURBIPROFEN[1] Flurbiprofen[2] Flurbiprofen ,
Flurbiprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[3] 13, 21, 46 💬
1006FMP30 Donor Stool----[1] 13 💬
1007FolateScan (Technetium Tc 99mEC20)----[4] 13, 46, 49, 96 💬
1008Foralumab[1] Foralumab---[3] 13, 17, 96 💬
1009Foralumab TZLS-401 100 µg[1] Foralumab---[1] 13 💬
1010Foralumab TZLS-401 50 µg[1] Foralumab---[1] 13 💬
1011FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----[1] 13 💬
1012Formistin 10 mg----[1] 13 💬
1013Formulation A----[1] 13 💬
1014Formulation B----[1] 13 💬
1015Formulation C----[1] 13 💬
1016Formulation D----[1] 13 💬
1017Frexalimab[1] Frexalimab[1] Frexalimab 💬 [1] CD40LG 💬 [14] Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬[3] 13, 222, 223 💬
1018FTY720----[1] 13 💬
1019FTY720D----[1] 13 💬
1020Full Spectrum vitamin----[1] 13 💬
1021Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----[1] 13 💬
1022Fumaric acid[1] Fumaric acid[1] Fumaric acid 💬 --[1] 13 💬
1023G-CSF[1] Filgrastim[1] Filgrastim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[12] 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
1024G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)----[1] 13 💬
1025GA----[1] 13 💬
1026GA 20 mg/mL----[1] 13 💬
1027GA 40 mg/mL----[1] 13 💬
1028GA Depot----[1] 13 💬
1029GA Depot 25mg once monthly----[1] 13 💬
1030GA Depot 40 mg----[1] 13 💬
1031GA Depot 40mg once monthly----[1] 13 💬
1032GA Depot 80 mg----[1] 13 💬
1033GABAPENTIN[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[7] 6, 13, 18, 19, 70, 226, 298 💬
1034Gabapentine[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 13 💬
1035Gabapentine 300mg[1] Gabapentin[1] Gabapentin 💬 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		[10] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[2] 13, 18 💬
1036Gadobenate Dimeglumine[1] Gadobenic acid[2] Gadobenate dimeglumine ,
Gadobenic acid 💬 		--[1] 13 💬
1037GADOBUTROL[1] Gadobutrol[1] Gadobutrol 💬 --[4] 13, 22, 46, 226 💬
1038Gadolinium[1] Gadolinium---[8] 13, 34, 46, 65, 77, 86, 113, 305 💬
1039Gadolinium-based contrast[1] Gadolinium---[1] 13 💬
1040Gadopentetate dimeglumine[1] Gadopentetic acid[2] Gadopentetate dimeglumine ,
Gadopentetic acid 💬 		--[2] 13, 34 💬
1041Gadoteric acid[1] Gadoteric acid[2] Gadoterate meglumine ,
Gadoteric acid 💬 		--[2] 13, 58 💬
1042Gadoteridol[1] Gadoteridol[1] Gadoteridol 💬 --[1] 13 💬
1043GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado----[1] 13 💬
1044Gadovist 1.0 mmol/ml Injektionslösung----[1] 13 💬
1045Gamma-Tocopherol[2] Tocopherol,
gamma-Tocopherol		[1] Tocopherol 💬 --[1] 13 💬
1046GBP----[2] 13, 18 💬
1047GC012F[1] GC012F---[6] 11, 13, 28, 46, 49, 51 💬
1048GC012F CAR-T Cell Injection[1] GC012F---[2] 13, 46 💬
1049GDC-0853----[3] 13, 46, 49 💬
1050GDC-0853 RO7010939----[3] 13, 46, 49 💬
1051Gemfibrozil[1] Gemfibrozil[1] Gemfibrozil 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[2] 6, 13 💬
1052Genetic: Biobanking with genetic analysis----[3] 13, 51, 56 💬
1053Genetic: Blood sample----[5] 8, 13, 61, 280, 294 💬
1054Genetic: Blood sampling----[2] 13, 49 💬
1055Genetic: miRNA----[1] 13 💬
1056Genetic: Nicotine dependence[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[1] 13 💬
1057Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.----[1] 13 💬
1058Genotropin----[6] 13, 77, 107, 187, 193, 222 💬
1059Gentamicin[1] Gentamicin[2] Gentamicin sulfate ,
Gentamicin 💬 		--[4] 13, 36, 113, 299 💬
1060Gilenya----[3] 2, 13, 14 💬
1061GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE----[1] 13 💬
1062GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE----[1] 13 💬
1063GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE----[1] 13 💬
1064GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE----[1] 13 💬
1065Gilenya 0,5 mg Hartkapseln----[1] 13 💬
1066Gilenya 0,5MG CPS DUR----[1] 13 💬
1067Gilenya hard capsules----[1] 13 💬
1068Gilenya hard capsulesProduct Name: FingolimodPharmaceutical Form: CapsuleINN or Proposed INN: FingolimodCAS Number: 162359-55-9Concentration unit: mg milligram(s)Concentration type: rangeConcentration number: 0.25-0.50Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use----[1] 13 💬
1069Gilenya®----[1] 13 💬
1070Gileyna----[1] 13 💬
1071Ginkgo biloba[1] Ginkgo biloba[1] Ginkgo 💬 --[4] 13, 18, 47, 90 💬
1072Ginseng[1] Ginseng[2] Red ginseng ,
Ginseng 💬 		--[3] 13, 46, 53 💬
1073Glatiramer[1] Glatiramer[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[4] 2, 13, 96, 156 💬
1074GLATIRAMER ACETATE[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[3] 13, 96, 156 💬
1075Glatiramer Acetate (Copaxone®)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[2] 13, 156 💬
1076Glatiramer Acetate (DB)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1077Glatiramer Acetate (GA)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1078Glatiramer Acetate (GA) 40 mg[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1079Glatiramer Acetate (GTR)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1080Glatiramer Acetate (OL)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1081Glatiramer acetate 150mg enteric coated tablets[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1082Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1083Glatiramer acetate 20 mg[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1084Glatiramer acetate 20 mg, with mitoxantrone[3] Acetate,
Glatiramer,
Mitoxantrone		[3] Mitoxantrone hydrochloride ,
Glatiramer acetate ,
Mitoxantrone 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1085Glatiramer Acetate 20 mg/0.5 mL[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1086Glatiramer acetate 40 mg[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1087Glatiramer Acetate [GA][2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1088Glatiramer acetate injection with oral cetirizine hydrochloride[3] Acetate,
Cetirizine,
Glatiramer		[3] Cetirizine hydrochloride ,
Glatiramer acetate ,
Cetirizine 💬 		[21] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
HRH1 💬 		[36] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1089Glatiramer acetate with minocycline[3] Acetate,
Glatiramer,
Minocycline		[3] Minocycline hydrochloride ,
Glatiramer acetate ,
Minocycline 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1090Glatiramer acetate, (Copaxone®)[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1091Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1092Glatiramer Acetate, N-Acetylcysteine[3] Acetate,
Acetylcysteine,
Glatiramer		[2] Acetylcysteine ,
Glatiramer acetate 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1093GLATIRAMER ACETATO[1] Glatiramer[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1094GLATIRAMERO ACETATO----[1] 13 💬
1095Glibenclamide----[1] 13 💬
1096Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato----[1] 13 💬
1097GLP-1----[2] 13, 299 💬
1098Glucose----[3] 6, 13, 299 💬
1099Glutamate and aspartate----[1] 13 💬
1100Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate----[1] 13 💬
1101GNbAC1----[1] 13 💬
1102GNbAC1 Monoclonal Antibody----[1] 13 💬
1103Gold[1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
1104Gold Nanocrystals[1] Gold---[3] 2, 6, 13 💬
1105Granulocyte-colony stimulating factor (G-CSF) and prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1106GSK1223249----[2] 2, 13 💬
1107GSK1841157----[3] 13, 35, 46 💬
1108GSK2018682----[1] 13 💬
1109GSK2018682 CD2 Capsule----[1] 13 💬
1110GSK2018682 CD3 micronised Tablet----[1] 13 💬
1111GSK2018682 CD3 non-micronised Tablet----[1] 13 💬
1112GSK2018682 CD3 non-micronised Tablet in fed state----[1] 13 💬
1113GSK239512----[1] 13 💬
1114GSK2395612----[1] 13 💬
1115GSK3888130B----[1] 13 💬
1116GTR----[1] 13 💬
1117GTR.ace----[1] 13 💬
1118GUANABENZ[1] Guanabenz[2] Guanabenz acetate ,
Guanabenz 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 2, 13 💬
1119GW-1000-02----[1] 13 💬
1120GYLENIA----[1] 13 💬
1121GYLENIA 0,5 mg----[1] 13 💬
1122GZ402668----[1] 13 💬
1123GZ402673----[1] 13 💬
1124H.P. Acthar Gel (repository corticotropin injection)[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 13 💬
1125H5G1.1-mAb----[3] 13, 50, 62 💬
1126HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)----[2] 13, 14 💬
1127HB-adMSCs----[8] 2, 4, 6, 13, 14, 46, 49, 113 💬
1128HBI0101 CART----[5] 11, 13, 46, 49, 51 💬
1129HBM9161 Injection----[1] 13 💬
1130Helminth ova----[1] 13 💬
1131Hematopoetic stem cell infusion----[1] 13 💬
1132Hematopoietic Stem Cell Therapy----[1] 13 💬
1133Hematopoietic Stem Cell Transplantation----[13] 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
1134Hematopoietic stem cell transplantation (HSCT)----[2] 13, 60 💬
1135Hesperidin[1] Hesperidin[1] Hesperidin 💬 --[3] 13, 46, 93 💬
1136Heterologous booster----[1] 13 💬
1137Hiberix----[1] 13 💬
1138Hidrocloruro de fingolimod[1] Fingolimod[3] Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		[1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14 💬
1139High Dose Aspirin (1300 mg/day)----[1] 13 💬
1140High Dose MYOBLOC (20,000 Units)----[1] 13 💬
1141High Phenolic Extra Virgin Olive Oil[1] Olive oil[1] Olive oil 💬 --[1] 13 💬
1142High-dose corticosteroid pulse therapy----[1] 13 💬
1143High-dose intravenous methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1144High-Intensity Focused Electromagnetic Therapy----[1] 13 💬
1145High/Low Sodium Diet----[1] 13 💬
1146Histamine[1] Histamine[3] Histamine dihydrochloride ,
Histamine phosphate ,
Histamine 💬 		[4] HRH1,
HRH2,
HRH3,
HRH4 💬 		[5] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
1147Histidine[1] Histidine[1] Histidine 💬 --[3] 13, 169, 170 💬
1148HMR 1726D----[1] 13 💬
1149HMR1726----[1] 13 💬
1150HMR1726D----[1] 13 💬
1151Home based balance training----[2] 6, 13 💬
1152Homologous booster----[1] 13 💬
1153Hookworm larvae----[1] 13 💬
1154HP 13C pyruvate injection----[1] 13 💬
1155HP184----[1] 13 💬
1156Human anti-IL-12 IgG1 Mab----[1] 13 💬
1157Human anti-IL-12 Mab----[1] 13 💬
1158Human anti-LINGO-1 monoclonal antibody----[1] 13 💬
1159Human autologous mesenchymal stem cells----[2] 2, 13 💬
1160Human fetal-derived Neural Stem Cells (hNSCs)----[1] 13 💬
1161Human interferon beta[1] Human interferon beta[1] Interferon beta 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[2] 13, 26 💬
1162Human interferon beta 1a (Rebif)[1] Human interferon beta[1] Interferon beta 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1163Human interferon beta-1a and glatiramer acetate[4] Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		[3] Interferon beta ,
Glatiramer acetate ,
Interferon beta-1a 💬 		[22] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
IFNAR1,
IFNAR2 💬 		[44] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Coronavirus disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1164HUMAN LEUCOCYTE INTERFERON-ALPHA----[1] 13 💬
1165Human monoclonal antibody (CNTO 1275) to interleukin-12p40----[1] 13 💬
1166Human Neural Stem Cells----[2] 2, 13 💬
1167Human normal immunoglobulin----[6] 13, 14, 50, 51, 63, 65 💬
1168Human recombinant growth hormone----[2] 13, 299 💬
1169Human Umbilical Cord Mesenchymal Stem Cells[1] Human Umbilical Cord Mesenchymal Stem Cells---[5] 13, 96, 97, 113, 271 💬
1170HuMax-CD20[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 13, 46 💬
1171Hyaluronidase[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[7] 13, 14, 28, 51, 60, 65, 331 💬
1172HYDROCHLOROTHIAZIDE[1] Hydrochlorothiazide[1] Hydrochlorothiazide 💬 [1] SLC12A3 💬 [1] Parathyroid hormone synthesis, secretion and action 💬[5] 13, 67, 222, 225, 235 💬
1173Hydrogen[1] Hydrogen---[8] 5, 6, 13, 17, 83, 97, 226, 238 💬
1174Hydrogen peroxide[2] Hydrogen,
Hydrogen peroxide		[1] Hydrogen peroxide 💬 --[1] 13 💬
1175Hydroxychloroquine[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[29] 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
1176Hydroxychloroquine Pill[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 13 💬
1177Hydroxychloroquine sulfate[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[5] 13, 46, 48, 53, 66 💬
1178Hydroxytyrosol[1] Hydroxytyrosol---[1] 13 💬
1179Hydroxyurea[1] Hydroxyurea[1] Hydroxyurea 💬 [1] RRM2 💬 [5] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬[10] 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
1180Hyperbaric oxygen treatment (HBOT)[1] Oxygen[1] Oxygen 💬 --[6] 13, 15, 36, 96, 97, 269 💬
1181Hyperimmune caprine serum against HIV lysate----[1] 13 💬
1182IBUDILAST[1] Ibudilast[1] Ibudilast 💬 [8] CYSLTR1,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PTGIR 💬 		[15] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 2, 13 💬
1183Ibuprofen[1] Ibuprofen[5] Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[8] 13, 46, 65, 96, 107, 113, 271, 299 💬
1184Ibuprofen Sandoz 400 mg Filmtabletten[1] Ibuprofen[5] Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
1185ICP-022----[3] 13, 46, 49 💬
1186Idebenone[1] Idebenone[1] Idebenone 💬 --[9] 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
1187IDMT----[1] 13 💬
1188IDP-023----[1] 13 💬
1189IFA Incomplete Freund's Adjuvant----[1] 13 💬
1190Ifenprodil[1] Ifenprodil[2] Ifenprodil tartrate ,
Ifenprodil 💬 		[3] ADRA1A,
ADRA1B,
ADRA1D 💬 		[9] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 13 💬
1191IFN beta 1a 44 mcg TIW----[1] 13 💬
1192IFN beta-1a----[1] 13 💬
1193IFN ß-1a----[1] 13 💬
1194IFN-beta-1a (Rebif®)----[1] 13 💬
1195IFN-beta-1a, (Avonex®)----[1] 13 💬
1196IFN-ß-1a (Rebif®)----[1] 13 💬
1197IFN-ß-1a, (Avonex®)----[1] 13 💬
1198IL2----[1] 13 💬
1199IM90838----[3] 13, 96, 97 💬
1200Imatinib[1] Imatinib[2] Imatinib mesylate ,
Imatinib 💬 		[3] ABL1,
KIT,
PDGFRA 💬 		[34] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1201IMATINIB MESILATE[1] Imatinib[2] Imatinib mesylate ,
Imatinib 💬 		[3] ABL1,
KIT,
PDGFRA 💬 		[34] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[3] 13, 86, 88 💬
1202Imatinib Mesylate[1] Imatinib[2] Imatinib mesylate ,
Imatinib 💬 		[3] ABL1,
KIT,
PDGFRA 💬 		[34] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[5] 13, 28, 34, 51, 86 💬
1203IMC-002----[1] 13 💬
1204IMCY-0141[1] IMCY-0141---[1] 13 💬
1205Immune globulin----[3] 11, 13, 14 💬
1206Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified----[1] 13 💬
1207Immunoadsorption----[2] 13, 14 💬
1208Immunoglobulin----[3] 13, 14, 63 💬
1209IMMUNOGLOBULIN G----[9] 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
1210IMMUNOSUPPRESSIVE AGENTS----[4] 13, 50, 96, 223 💬
1211IMS001----[1] 13 💬
1212IMU-838----[3] 13, 96, 97 💬
1213IMU-838 (10 mg/day)----[1] 13 💬
1214IMU-838 (30 mg/day)----[1] 13 💬
1215IMU-838 (45 mg/day)----[1] 13 💬
1216IMU-838 tablets----[1] 13 💬
1217IMU-838-RC----[1] 13 💬
1218IMUREL----[7] 13, 44, 45, 46, 54, 96, 97 💬
1219IncabotulinumtoxinA----[1] 13 💬
1220Incobotulinum Toxin A----[3] 2, 6, 13 💬
1221Indapamide[1] Indapamide[1] Indapamide 💬 [1] SLC12A3 💬 [1] Parathyroid hormone synthesis, secretion and action 💬[2] 13, 235 💬
1222Indapamide Pill[1] Indapamide[1] Indapamide 💬 [1] SLC12A3 💬 [1] Parathyroid hormone synthesis, secretion and action 💬[1] 13 💬
1223Indole[1] Indole---[2] 13, 51 💬
1224Indole-3-propionic acid (IPA)[1] Indole---[1] 13 💬
1225INEBILIZUMAB[1] Inebilizumab[1] Inebilizumab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[8] 11, 13, 46, 49, 51, 53, 95, 300 💬
1226Inebilizumab + Rapid Steroid Tapering group[1] Inebilizumab[1] Inebilizumab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[1] 13 💬
1227Inebilizumab + Standard Steroid Tapering group[1] Inebilizumab[1] Inebilizumab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[1] 13 💬
1228INF beta-1a----[1] 13 💬
1229Influenza vaccine----[6] 11, 13, 46, 51, 84, 97 💬
1230Inhaled Cannabis----[1] 13 💬
1231Injectable MS DMT----[1] 13 💬
1232Injection of autologous bone marrow derived mesenchymal stem cells----[1] 13 💬
1233Injection of cell free media----[1] 13 💬
1234INN COLECALCIFEROL----[1] 13 💬
1235Inosine[1] Inosine[1] Inosine 💬 --[5] 2, 6, 13, 17, 122 💬
1236Insulin----[6] 6, 13, 46, 75, 77, 299 💬
1237INT131----[1] 13 💬
1238Inteferone Beta-1A----[1] 13 💬
1239Integrated Dual-task EMG Biofeedback Training (EMG-BF)----[1] 13 💬
1240Interferon Beta----[2] 13, 20 💬
1241INTERFERON BETA - 1A----[1] 13 💬
1242Interferon beta - 1a (IFN)----[1] 13 💬
1243Interferon beta -1b[1] Human interferon beta[1] Interferon beta 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1244Interferon Beta 1----[1] 13 💬
1245Interferon Beta 1-A[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1246Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)----[1] 13 💬
1247Interferon Beta 1a[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1248Interferon beta 1a 30 ug IM once weekly----[1] 13 💬
1249Interferon Beta 1a pegilado----[1] 13 💬
1250Interferon beta 1a, oral doxycycline[1] Doxycycline[5] Doxycycline ,
Doxycycline hyclate ,
Doxycycline calcium ,
Doxycycline ,
Doxycycline hydrochloride 💬 		--[1] 13 💬
1251Interferon beta 1B----[1] 13 💬
1252Interferon beta 1b (Betaseron, BAY86-5046)----[1] 13 💬
1253Interferon Beta Therapy----[1] 13 💬
1254Interferon beta treatment to add-on atorvastatin treatment[1] Atorvastatin[2] Atorvastatin calcium ,
Atorvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
1255Interferon beta type 1a----[1] 13 💬
1256Interferon beta-1 a----[1] 13 💬
1257INTERFERON BETA-1A[2] Human interferon beta,
Interferon beta-1a		[2] Interferon beta ,
Interferon beta-1a 💬 		[2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[5] 13, 14, 26, 96, 97 💬
1258Interferon beta-1a (Avonex)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1259INTERFERON BETA-1A (Avonex®)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1260Interferon beta-1a (current approved manufacturing process invloving FBS)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1261Interferon beta-1a (new process, manufactured without FBS)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1262Interferon beta-1a (Rebif)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1263Interferon beta-1a (Rebif®) alone[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1264Interferon beta-1a 30 µg[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1265Interferon beta-1a FBS-free/HSA free, RNF[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1266Interferon beta-1a FBS-free/HSA-free[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1267Interferon beta-1a FBS-free/HSA-free, RNF[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1268Interferon beta-1a HSA+ biosimilar[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1269Interferon beta-1a HSA-free biosimilar[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1270Interferon beta-1a original[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1271Interferon Beta-1A Prefilled Syringe[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1272INTERFERON BETA-1B[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1273Interferon beta-1b (Betaferon, BAY 86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1274Interferon beta-1b (Betaferon, BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1275Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1276Interferon beta-1b (Betaferon®, BAY 86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1277Interferon beta-1b (Betaseron, BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1278Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1279Interferon beta-1b (PF530, Betaferon)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1280Interferon beta-1b and Tacrolimus[2] Interferon beta-1b,
Tacrolimus		[3] Tacrolimus ,
Interferon beta-1b ,
Tacrolimus 💬 		[7] IFNAR1,
IFNAR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[48] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
1281Interferon beta-1b group[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1282Interferon beta-1b, (Betaseron BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1283Interferon beta-1b, FRP about 6 weeks after randomization[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1284Interferon beta-1b, FRP within 15 days after randomization[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1285Interferon beta-1b/Atorvastatin group[2] Atorvastatin,
Interferon beta-1b		[3] Interferon beta-1b ,
Atorvastatin calcium ,
Atorvastatin 💬 		[3] HMGCR,
IFNAR1,
IFNAR2 💬 		[21] AMPK signaling pathway, Bile secretion, Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway 💬[1] 13 💬
1286INTERFERON BETA1A----[1] 13 💬
1287Interferon or glatiramer acetate[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1288Interferon ß-1a----[1] 13 💬
1289Interferon ß-1a 30 µg----[1] 13 💬
1290Interferon ß-1b----[1] 13 💬
1291Interferon-1beta (Betaseron, BAY86-5046)----[1] 13 💬
1292Interferon-Beta----[1] 13 💬
1293Interferon-beta (IFN-beta)----[1] 13 💬
1294Interferon-beta 1a----[1] 13 💬
1295Interferon-beta 1a FBS-free/HSA free, RNF----[1] 13 💬
1296Interferon-beta 1a FBS-free/HSA-free, RNF----[1] 13 💬
1297Interferon-beta 1b----[1] 13 💬
1298Interferon-beta 1b (Betaseron)----[1] 13 💬
1299Interferon-beta [IFN-beta]----[1] 13 💬
1300Interferon-beta and human leukocyte Interferon-a----[1] 13 💬
1301Interferon-beta-1----[1] 13 💬
1302Interferon-beta-1a[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1303Interferon-beta-1a (Avonex) plus methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1304Interferon-beta-1a FBS-free/HSA free, RNF----[1] 13 💬
1305Interferon-beta-1a FBS-free/HSA-free----[1] 13 💬
1306Interferon-beta-1b[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1307Interferon-beta-1b (BETASERON, BAY 86-5046)----[1] 13 💬
1308Interferon-beta1----[1] 13 💬
1309Interferon-ß----[1] 13 💬
1310Interferon-ß [IFN-ß]----[1] 13 💬
1311Interferon-ß-1----[1] 13 💬
1312Interferon-ß-1a----[1] 13 💬
1313Interferon-ß-1b----[1] 13 💬
1314Interferone----[1] 13 💬
1315Interferone beta 1a----[1] 13 💬
1316INTERFERONE BETA 1B----[1] 13 💬
1317Interferone beta-1a----[1] 13 💬
1318Interferone Beta-1B----[1] 13 💬
1319Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab[12] Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		[13] Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Fingolimod hydrochloride ,
Glatiramer acetate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod ,
Fingolimod lauryl sulfate 💬 		[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬 		[58] Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬[1] 13 💬
1320Interferón beta 1a----[1] 13 💬
1321Interferón beta 1a pegilado----[1] 13 💬
1322Interferón Beta-1a pegilado----[1] 13 💬
1323Interleukin-2----[6] 2, 13, 49, 50, 55, 65 💬
1324Intermittent theta burst stimulation (iTBS) therapeutic protocol for spasticity----[1] 13 💬
1325Intra-detrusor injection of Onabotulinumtoxin-A----[1] 13 💬
1326Intranasal Foralumab Solution[1] Foralumab---[1] 13 💬
1327Intratect----[4] 13, 14, 35, 65 💬
1328Intrathecal administration of autologous MSC-NP----[1] 13 💬
1329Intrathecal methotrexate[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 13 💬
1330Intrathecal MSC-NP injection----[1] 13 💬
1331Intravenous (IV) infusions----[2] 13, 97 💬
1332Intravenous Glucocorticoids----[1] 13 💬
1333Intravenous Immunoglobulin----[9] 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
1334Intravenous injection of mesenchymal stem cells----[1] 13 💬
1335Intravenous Methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 97, 145 💬
1336Intravenous Methylprednisolone (IVMP)[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1337Intravenous methylprednisolone (IVMP) and Efgartigimod[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1338Intravenous steroid----[1] 13 💬
1339Ipilimumab[1] Ipilimumab[1] Ipilimumab 💬 [1] CTLA4 💬 [4] Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬[9] 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
1340IPX056----[1] 13 💬
1341IPX056 10 mg----[1] 13 💬
1342IPX056 20 mg----[1] 13 💬
1343IPX056 30 mg----[1] 13 💬
1344IPX056 35 mg----[1] 13 💬
1345IPX056 40 mg----[1] 13 💬
1346IPX056-10 mg----[1] 13 💬
1347IPX056-20 mg----[1] 13 💬
1348IPX056-25 mg----[1] 13 💬
1349IPX056-30 mg----[1] 13 💬
1350IPX056-35 mg----[1] 13 💬
1351IPX056-40 mg----[1] 13 💬
1352IR902----[1] 13 💬
1353Irradiation----[1] 13 💬
1354ISENTRESS----[1] 13 💬
1355Isoxsuprine[1] Isoxsuprine[2] Isoxsuprine hydrochloride ,
Isoxsuprine 💬 		[1] ADRB2 💬 [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
1356Isoxsuprine Hydrochloride[1] Isoxsuprine[2] Isoxsuprine hydrochloride ,
Isoxsuprine 💬 		[1] ADRB2 💬 [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
1357IV methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1358IV methylprednisolone (steroids)[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1359IVIG----[8] 11, 13, 14, 18, 51, 63, 65, 172 💬
1360IVIG+IVMP----[1] 13 💬
1361IVL3004----[1] 13 💬
1362IVL4002----[1] 13 💬
1363IVMP----[1] 13 💬
1364Ixazomib[1] Ixazomib[2] Ixazomib ,
Ixazomib citrate 💬 		[1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[4] 13, 16, 28, 51 💬
1365Ixazomib (NINLARO®) capsules[1] Ixazomib[2] Ixazomib ,
Ixazomib citrate 💬 		[1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 13 💬
1366JM-4----[1] 13 💬
1367JNJ-67896153/ACT-128800----[1] 13 💬
1368JYP0061----[1] 13 💬
1369Kemstro----[1] 13 💬
1370Kepivance----[1] 13 💬
1371KEPPRA----[1] 13 💬
1372Keppra 250mg----[1] 13 💬
1373Keppra 500mg----[1] 13 💬
1374Keppra ®----[1] 13 💬
1375Kesimpta----[1] 13 💬
1376Kesimpta 20 mg Injektionslösung im Fertigpen----[1] 13 💬
1377Kesimpta 20 mg solution for injection in pre-filled pen----[1] 13 💬
1378KETAMINE[1] Ketamine[2] Ketamine hydrochloride ,
Ketamine 💬 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[6] 6, 13, 70, 113, 156, 215 💬
1379Ketoconazole[1] Ketoconazole[1] Ketoconazole 💬 --[3] 8, 13, 75 💬
1380Ketogenic Diet----[7] 13, 21, 49, 77, 127, 145, 148 💬
1381Ketoprofen[1] Ketoprofen[3] Ketoprofen ,
Ketoprofen lysine ,
Ketoprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 13, 46 💬
1382Keyhole limpet hemocyanin[1] Keyhole limpet hemocyanin---[2] 13, 46 💬
1383Keyhole limpet hemocyanin (KLH)[1] Keyhole limpet hemocyanin---[1] 13 💬
1384Keyhole limpet hemocyanin (KLH) neo-antigen[1] Keyhole limpet hemocyanin---[1] 13 💬
1385Kirunal Fish Oil[1] Fish oil---[1] 13 💬
1386KITE-363----[5] 11, 13, 14, 49, 51 💬
1387KLH----[2] 13, 65 💬
1388KSVCBD injection----[1] 13 💬
1389KYV-101[1] KYV-101---[5] 11, 13, 46, 50, 51 💬
1390KYV-101 (Biological) - 0.33 ×10^8 cells[1] KYV-101---[1] 13 💬
1391KYV-101 (Biological) - 1 ×10^8 cells[1] KYV-101---[1] 13 💬
1392KYV-101 anti-CD19 CAR-T cell therapy[1] KYV-101---[1] 13 💬
1393L acetyl carnitine----[1] 13 💬
1394L-000124467----[2] 13, 46 💬
1395L-Carnitine----[5] 13, 46, 86, 96, 240 💬
1396L-Histidine[1] Histidine[1] Histidine 💬 --[1] 13 💬
1397L01BB04----[1] 13 💬
1398L03 AB----[1] 13 💬
1399L03 AB 08----[1] 13 💬
1400L03 AB07----[1] 13 💬
1401L03AB13----[1] 13 💬
1402L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE----[1] 13 💬
1403L04AA31----[1] 13 💬
1404Lactibane Iki----[1] 13 💬
1405Lactobacillus Rhamnosus GG----[2] 13, 299 💬
1406Lactose[1] Lactose[2] Anhydrous lactose ,
Lactose hydrate 💬 		--[8] 2, 6, 13, 21, 97, 107, 228, 310 💬
1407Lactose monohydrate[1] Lactose[2] Anhydrous lactose ,
Lactose hydrate 💬 		--[1] 13 💬
1408Lactulose[1] Lactulose[1] Lactulose 💬 --[5] 6, 13, 96, 97, 291 💬
1409Lamotrigine[1] Lamotrigine[1] Lamotrigine 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[7] 13, 34, 38, 113, 114, 115, 144 💬
1410Lamotrigine extended release tablets[1] Lamotrigine[1] Lamotrigine 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 13 💬
1411LAQUINIMOD[1] Laquinimod[1] Laquinimod sodium 💬 --[4] 8, 13, 49, 96 💬
1412Laquinimod 0.3[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1413Laquinimod 0.6[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1414Laquinimod 1.2[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1415Laquinimod Capsulas 0.6 mg[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1416Laquinimod Capsules 0.3 mg[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1417Laquinimod Capsules 0.6 mg[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1418Laquinimod Sodium (USAN)[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1419Laquinimod Tablets 0.3 mg[1] Laquinimod[1] Laquinimod sodium 💬 --[1] 13 💬
1420Lavender oil[1] Lavender oil[1] Lavender oil 💬 --[1] 13 💬
1421LCAR-AIO T cells----[3] 11, 13, 49 💬
1422Lemtrada----[2] 13, 65 💬
1423LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung----[1] 13 💬
1424Lenograstim[1] Lenograstim[1] Lenograstim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[8] 2, 13, 16, 18, 19, 57, 65, 97 💬
1425Leucovorin[1] Leucovorin[3] Leucovorin calcium ,
Folinic acid ,
Folinic acid calcium salt pentahydrate 💬 		--[3] 13, 19, 46 💬
1426Levetiracetam[1] Levetiracetam[1] Levetiracetam 💬 [1] SV2A 💬 [1] ECM-receptor interaction 💬[7] 2, 4, 6, 13, 34, 149, 307 💬
1427Levitra----[2] 13, 86 💬
1428Levocarnil----[1] 13 💬
1429LEVOFOLENE 4 MG 30 CPR----[1] 13 💬
1430LEVONORGESTREL[1] Levonorgestrel[1] Levonorgestrel 💬 [1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
1431LFB-R603----[1] 13 💬
1432LFB-R603, TGTX1101----[1] 13 💬
1433Lidocaine[1] Lidocaine[3] Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[14] 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
1434Lidocaine patch 5%[1] Lidocaine[3] Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 13 💬
1435Linoleic acid[1] Linoleic acid---[4] 2, 5, 13, 299 💬
1436Linoleic Acid/Oleic Acid[2] Linoleic acid,
Oleic Acid		[1] Oleic acid 💬 --[1] 13 💬
1437Liofen XL----[1] 13 💬
1438Liothyronine[1] Liothyronine[2] Liothyronine sodium ,
Liothyronine 💬 		[2] THRA,
THRB 💬 		[3] Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[3] 13, 210, 212 💬
1439Liothyronine sodium[1] Liothyronine[2] Liothyronine sodium ,
Liothyronine 💬 		[2] THRA,
THRB 💬 		[3] Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[1] 13 💬
1440Lipoic acid[1] Lipoic acid[1] Thioctic acid 💬 --[6] 2, 5, 13, 14, 20, 97 💬
1441Lipoic acid (LA) with fish oil and LA without fish oil[2] Fish oil,
Lipoic acid		[1] Thioctic acid 💬 --[1] 13 💬
1442Lipoic acid and omega-3 fatty acids[2] Lipoic acid,
Omega-3 fatty acids		[1] Thioctic acid 💬 --[1] 13 💬
1443Liraglutide[1] Liraglutide[1] Liraglutide 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 6, 13, 75, 77, 193 💬
1444Liraglutide Pen Injector [Saxenda][1] Liraglutide[1] Liraglutide 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 13 💬
1445Lisdexamfetamine[1] Lisdexamfetamine[2] Lisdexamfetamine dimesylate ,
Lisdexamfetamine 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
1446Lisdexamfetamine sulfate[1] Lisdexamfetamine[2] Lisdexamfetamine dimesylate ,
Lisdexamfetamine 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
1447Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field----[1] 13 💬
1448LITHIUM CARBONATE[1] Lithium carbonate[1] Lithium carbonate 💬 --[6] 2, 13, 17, 18, 127, 310 💬
1449Live Hookworm Larvae----[1] 13 💬
1450Live Necator americanus larvae----[1] 13 💬
1451Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)----[1] 13 💬
1452Lodosyn----[1] 13 💬
1453Lokomat training----[1] 13 💬
1454Loperamide[1] Loperamide[2] Loperamide hydrochloride ,
Loperamide 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 13, 97 💬
1455Loratadine[1] Loratadine[1] Loratadine 💬 [1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 13, 19, 46, 89, 98 💬
1456LOU064[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 13, 53 💬
1457LOU064C1----[1] 13 💬
1458Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day[1] Vitamin D---[1] 13 💬
1459Low Dose Aspirin (162 mg/day)----[1] 13 💬
1460Low dose cannabis----[1] 13 💬
1461Low Dose MYOBLOC (10,000 Units)----[1] 13 💬
1462Low immunogenic interferon-beta-1a----[1] 13 💬
1463Low-Dose Naltrexone (LDN)[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[3] 13, 46, 49 💬
1464Low-Frequency Electromagnetic Resonance Therapy (LF-EMR)----[3] 13, 46, 49 💬
1465LP-168 tablet----[1] 13 💬
1466LPX-TI641----[2] 13, 46 💬
1467Lu AG06466----[1] 13 💬
1468LUBIPROSTONE[1] Lubiprostone[1] Lubiprostone 💬 [1] CLCN2 💬 [1] Mineral absorption 💬[5] 6, 13, 97, 290, 299 💬
1469Lumbar puncture----[9] 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
1470Lumbar puncture and blood withdrawal----[1] 13 💬
1471Lutein[1] Lutein---[3] 13, 90, 164 💬
1472LUTENYL----[1] 13 💬
1473LVIVO-TaVec400 product----[4] 11, 13, 49, 300 💬
1474LY2127399----[3] 13, 46, 49 💬
1475LY248686----[1] 13 💬
1476LY3541860----[2] 13, 46 💬
1477Lymphodepleting Conditioning----[3] 11, 13, 14 💬
1478Lysine[1] Lysine[4] Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--[4] 13, 97, 228, 299 💬
1479M2951----[3] 13, 46, 49 💬
1480Mab Therapy----[1] 13 💬
1481MABCAMPATH----[3] 13, 60, 65 💬
1482MABCAMPATH 10 mg/ml concentrado para solución para perfusión----[1] 13 💬
1483MabCampath ®----[1] 13 💬
1484MabCampath-1h----[1] 13 💬
1485MabCampath®----[1] 13 💬
1486Mabthera----[20] 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
1487MabThera (Rituximab)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[4] 13, 46, 49, 53 💬
1488Mabthera or biosimilar rituximab product[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1489Mabthera®----[7] 13, 35, 43, 44, 46, 63, 93 💬
1490Magnesium[1] Magnesium---[23] 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
1491Magnetic Resonance Imaging----[10] 6, 13, 19, 22, 28, 34, 65, 205, 285, 299 💬
1492Maltodextrin[1] Maltodextrin[1] Maltodextrin 💬 --[4] 6, 13, 96, 97 💬
1493Maltodextrin fiber supplement[1] Maltodextrin[1] Maltodextrin 💬 --[1] 13 💬
1494Mangafodipir[1] Mangafodipir[2] Mangafodipir trisodium ,
Mangafodipir 💬 		--[3] 13, 57, 58 💬
1495Mangafodipir (Teslascan)[1] Mangafodipir[2] Mangafodipir trisodium ,
Mangafodipir 💬 		--[1] 13 💬
1496Mannitol[1] Mannitol[1] Mannitol 💬 --[8] 6, 13, 21, 28, 60, 96, 113, 299 💬
1497Mannose[1] Mannose[1] Demannose 💬 --[2] 13, 256 💬
1498MANTADAN*20CPR 100MG----[1] 13 💬
1499Masitinb mesylate----[1] 13 💬
1500MASITINIB[1] Masitinib[1] Masitinib 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[6] 2, 5, 6, 13, 46, 96 💬
1501Masitinib (4.5)[1] Masitinib[1] Masitinib 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[2] 2, 13 💬
1502Masitinib 100 mg[1] Masitinib[1] Masitinib 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[1] 13 💬
1503Masitinib 200 mg[1] Masitinib[1] Masitinib 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[1] 13 💬
1504Masitinib mesilate[1] Masitinib[1] Masitinib 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[2] 2, 13 💬
1505Masitinib mesilato[1] Masitinib[1] Masitinib 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[1] 13 💬
1506MASITINIB MESYLATE[1] Masitinib[1] Masitinib 💬 [1] KIT 💬 [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬[6] 2, 5, 6, 13, 46, 96 💬
1507Mastinib----[1] 13 💬
1508MAVENCLAD----[1] 13 💬
1509MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE----[1] 13 💬
1510MAVENCLAD 10 mg tablets----[1] 13 💬
1511Mavenclad 10MG TBL NOB----[1] 13 💬
1512MAVENCLAD 6CPR 10 mg----[1] 13 💬
1513MAVENCLAD 6CPR 10mg----[1] 13 💬
1514Mavenclad tabletter 10 mg----[1] 13 💬
1515Mavenclad®----[1] 13 💬
1516Mayzent----[1] 13 💬
1517Mayzent 0,25 mg compresse rivestite con film----[1] 13 💬
1518Mayzent 0,25 mg Filmtabletten----[1] 13 💬
1519Mayzent 0.25 mg fi----[1] 13 💬
1520Mayzent 2 mg compresse rivestite con film----[1] 13 💬
1521Mayzent 2 mg film-coated tablets----[1] 13 💬
1522Mayzent 2 mg Filmtabletten----[1] 13 💬
1523MB-CART2019.1----[1] 13 💬
1524MBP peptide----[1] 13 💬
1525MBP8298----[1] 13 💬
1526MBP8298 Synthetic Peptide----[1] 13 💬
1527MC1----[3] 6, 13, 46 💬
1528MD1003----[5] 2, 10, 13, 14, 20 💬
1529MD1003 100mg capsule----[1] 13 💬
1530MEDI-551----[2] 13, 51 💬
1531MEDI-551 100 MG-IV----[1] 13 💬
1532MEDI-551 30 MG-IV----[1] 13 💬
1533MEDI-551 300 MG-SC----[1] 13 💬
1534MEDI-551 60 MG-SC----[1] 13 💬
1535MEDI-551 600 MG-IV----[1] 13 💬
1536Medical Marijuana----[1] 13 💬
1537Medication Event Monitoring System (MEMS)----[1] 13 💬
1538Mediterranean Diet----[4] 13, 77, 97, 265 💬
1539Medrol----[4] 13, 46, 56, 222 💬
1540Megadose oral methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1541Melatonin[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[18] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
1542Melphalan[1] Melphalan[2] Melphalan ,
Melphalan hydrochloride 💬 		--[19] 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
1543Memantine[1] Memantine[2] Memantine hydrochloride ,
Memantine 💬 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[8] 2, 6, 8, 13, 49, 127, 205, 206 💬
1544Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)----[1] 13 💬
1545Menitorix----[1] 13 💬
1546Menveo----[4] 11, 13, 62, 223 💬
1547Mesenchymal stem cells----[16] 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
1548Mesenchymal stem cells (MSC)----[3] 2, 13, 96 💬
1549Mesenchymal stem cells (MSCs)----[4] 13, 36, 96, 97 💬
1550Mesenchymal stem/stromal cells----[1] 13 💬
1551Mesna[1] Coenzyme M[1] Mesna 💬 --[12] 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
1552Metabolic fatigue----[1] 13 💬
1553Metex----[2] 13, 46 💬
1554Metformin[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[31] 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
1555Metformin (Cidophage®)[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 13 💬
1556MetFORMIN 1000 Mg Oral Tablet[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 13 💬
1557Metformin 500 Mg Oral Tablet, up to 4 tablets a day[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 13 💬
1558Metformin and clemastine in combination[2] Clemastine,
Metformin		[4] Clemastine fumarate ,
Metformin hydrochloride ,
Clemastine ,
Metformin 💬 		[3] HRH1,
PRKAA1,
PRKAA2 💬 		[24] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Calcium signaling pathway, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Inflammatory mediator regulation of TRP channels, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 13 💬
1559Metformin Hydrochloride 850 mg Oral Tablet[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 13 💬
1560Methelphenidate----[1] 13 💬
1561Methotrexat[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[3] 13, 46, 96 💬
1562Methotrexate[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[41] 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
1563Methyl B12----[1] 13 💬
1564Methyl folate----[1] 13 💬
1565Methyl Prednisolonate----[1] 13 💬
1566Methyloprednisolone----[1] 13 💬
1567Methylphenidate[1] Methylphenidate[2] Methylphenidate hydrochloride ,
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[7] 6, 13, 34, 84, 113, 179, 206 💬
1568METHYLPHENIDATE HYDROCHLORIDE[1] Methylphenidate[2] Methylphenidate hydrochloride ,
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[2] 6, 13 💬
1569Methylphenidate modified release[1] Methylphenidate[2] Methylphenidate hydrochloride ,
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
1570Methylphenidate modified release 20 mg[1] Methylphenidate[2] Methylphenidate hydrochloride ,
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
1571Methylphenidate modified release 30 mg[1] Methylphenidate[2] Methylphenidate hydrochloride ,
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
1572Methylphenidate modified release 40 mg[1] Methylphenidate[2] Methylphenidate hydrochloride ,
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
1573Methylprednisolon-21-hydrogensuccinat, Natriumsalz[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1574Methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[51] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
1575Methylprednisolone (drug)[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
1576Methylprednisolone 1250 mg/24h x3 days[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1577Methylprednisolone hemisuccinate[2] Methylprednisolone,
Methylprednisolone hemisuccinate		[4] Methylprednisolone ,
Methylprednisolone sodium succinate ,
Methylprednisolone acetate ,
Methylprednisolone hemisuccinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 85 💬
1578Methylprednisolone IV[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1579Methylprednisolone PO[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1580METHYLPREDNISOLONE SODIUM HEMISUCCINATE[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 85, 97 💬
1581METHYLPREDNISOLONE SODIUM SUCCINATE[3] Methylprednisolone,
Methylprednisolone hemisuccinate,
Succinic acid		[4] Methylprednisolone ,
Methylprednisolone sodium succinate ,
Methylprednisolone acetate ,
Methylprednisolone hemisuccinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[7] 13, 46, 49, 50, 51, 211, 222 💬
1582Methylprednisolone succinate[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
1583Metilprednisolone sodio succinato----[4] 13, 14, 56, 66 💬
1584Microgynon----[2] 13, 51 💬
1585Microgynon®----[1] 13 💬
1586Micropirin----[1] 13 💬
1587Midazolam[1] Midazolam[3] Midazolam ,
Midazolam hydrochloride ,
Midazolam maleate 💬 		[16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[14] 2, 3, 6, 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
1588MIL62----[3] 13, 49, 222 💬
1589Mild dose cannabis----[1] 13 💬
1590Mineral boost (magnesium)[1] Magnesium---[1] 13 💬
1591Minocycline[1] Minocycline[2] Minocycline hydrochloride ,
Minocycline 💬 		--[14] 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
1592Minocycline 100 mg Film-coated Tablets[1] Minocycline[2] Minocycline hydrochloride ,
Minocycline 💬 		--[1] 13 💬
1593Minocycline 100mg[1] Minocycline[2] Minocycline hydrochloride ,
Minocycline 💬 		--[2] 13, 90 💬
1594Minocycline Hydrochloride[1] Minocycline[2] Minocycline hydrochloride ,
Minocycline 💬 		--[4] 13, 201, 206, 299 💬
1595Mirabegron[1] Mirabegron[1] Mirabegron 💬 [1] ADRB3 💬 [9] Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬[4] 6, 13, 53, 226 💬
1596MIS416----[1] 13 💬
1597Mitoquinone[1] Mitoquinone---[1] 13 💬
1598Mitoxantrone[1] Mitoxantrone[2] Mitoxantrone hydrochloride ,
Mitoxantrone 💬 		--[1] 13 💬
1599Mitoxantrone Hydrochloride Liposome Injection[1] Mitoxantrone[2] Mitoxantrone hydrochloride ,
Mitoxantrone 💬 		--[1] 13 💬
1600MK0812----[2] 13, 46 💬
1601MLN1202----[1] 13 💬
1602MODAFINIL[1] Modafinil[1] Modafinil 💬 --[6] 6, 13, 49, 93, 96, 97 💬
1603Modafinil Generis 100 mg[1] Modafinil[1] Modafinil 💬 --[1] 13 💬
1604Moderna mRNA-1273----[7] 13, 35, 46, 49, 50, 51, 107 💬
1605Moderna mRNA-1273, Bivalent----[7] 13, 35, 46, 49, 50, 51, 107 💬
1606MOG peptide----[1] 13 💬
1607Monoclonal antibody M-T412----[1] 13 💬
1608Monoclonal CD-20 antibodies----[1] 13 💬
1609Monomethyl Fumarate[1] Monomethyl fumarate[1] Monomethyl fumarate 💬 --[1] 13 💬
1610Monomethyl fumarate 190 mg[1] Monomethyl fumarate[1] Monomethyl fumarate 💬 --[1] 13 💬
1611Monovalent [B.1.351] CoV2 preS dTM-AS03----[7] 13, 35, 46, 49, 50, 51, 107 💬
1612Montelukast[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬 		[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[10] 6, 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
1613MOR103----[2] 13, 46 💬
1614Most recent vaccine to seasonal influenza----[1] 13 💬
1615MRI----[6] 13, 48, 70, 77, 85, 278 💬
1616MRI contrast-enhancing agents----[1] 13 💬
1617MRI contrast-enhancing preparations----[1] 13 💬
1618MRI Scanner----[1] 13 💬
1619MRNA COVID-19 vaccine----[1] 13 💬
1620MRNA-1195----[1] 13 💬
1621MRNA-1273----[1] 13 💬
1622MS disease modifying drugs (MSDMDs)----[1] 13 💬
1623MSC-Derived Exosomes----[1] 13 💬
1624MSC2015----[1] 13 💬
1625MSC2304479A----[1] 13 💬
1626MSC2304480A----[1] 13 💬
1627MSC2304481A----[1] 13 💬
1628MSC2304482A----[1] 13 💬
1629MSC2358825A----[1] 13 💬
1630MSC2364447C----[2] 13, 49 💬
1631MSC2430913A or ONO-4641 (to be used as synonyms)----[1] 13 💬
1632MSC2491529A----[1] 13 💬
1633MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1634MSTC-001 (MS-STAT)----[1] 13 💬
1635MT-1303----[3] 13, 96, 97 💬
1636MT-1303 [0.1]----[1] 13 💬
1637MT-1303 [0.2]----[1] 13 💬
1638MT-1303 [0.4]----[1] 13 💬
1639MT-1303-FormA----[1] 13 💬
1640MT-1303-FormB----[1] 13 💬
1641MT-1303-High----[1] 13 💬
1642MT-1303-Low----[1] 13 💬
1643MT-1303-Middle----[1] 13 💬
1644MTM-H-001 Injection----[3] 11, 13, 46 💬
1645MTR-601----[1] 13 💬
1646Multiferon----[1] 13 💬
1647Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)----[1] 13 💬
1648Mutagrip----[2] 11, 13 💬
1649MyBETAapp----[1] 13 💬
1650Mycophenolate mofetil[2] Mycophenolate mofetil,
Mycophenolic acid		[4] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		[2] IMPDH1,
IMPDH2 💬 		[2] Drug metabolism - other enzymes, Purine metabolism 💬[38] 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
1651Mycophenolate mofetil (CellCept)[1] Mycophenolate mofetil[2] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[2] IMPDH1,
IMPDH2 💬 		[2] Drug metabolism - other enzymes, Purine metabolism 💬[3] 11, 13, 223 💬
1652Mycophenolate mofetil (MMF)[1] Mycophenolate mofetil[2] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[2] IMPDH1,
IMPDH2 💬 		[2] Drug metabolism - other enzymes, Purine metabolism 💬[8] 13, 49, 51, 60, 65, 66, 222, 223 💬
1653Mycophenolate mofetil, MMF[1] Mycophenolate mofetil[2] Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[2] IMPDH1,
IMPDH2 💬 		[2] Drug metabolism - other enzymes, Purine metabolism 💬[1] 13 💬
1654Myeloablative regimen----[1] 13 💬
1655MYOBLOC----[1] 13 💬
1656Méthylprednisolone----[1] 13 💬
1657Méthylprednisolone Mylan----[1] 13 💬
1658N acetylcysteine[1] Acetylcysteine[1] Acetylcysteine 💬 --[1] 13 💬
1659N-acetyl Cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬 		--[6] 13, 34, 85, 88, 296, 310 💬
1660N-Acetylcysteine[1] Acetylcysteine[1] Acetylcysteine 💬 --[14] 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
1661N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----[1] 13 💬
1662N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197----[1] 13 💬
1663N.a.----[11] 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
1664N02BG10----[1] 13 💬
1665N03AX12----[1] 13 💬
1666N06DX01----[1] 13 💬
1667Na18F----[1] 13 💬
1668NABILONE[1] Nabilone[1] Nabilone 💬 [2] CNR1,
CNR2 💬 		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[4] 6, 13, 97, 127 💬
1669Nabiximols[1] Nabiximols[1] Nabiximols 💬 --[1] 13 💬
1670Nabiximols - Sativex[1] Nabiximols[1] Nabiximols 💬 --[1] 13 💬
1671Naltrexone[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[14] 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
1672Namisol----[2] 13, 298 💬
1673Nanocort----[3] 13, 46, 97 💬
1674Nanocurcumin----[2] 13, 271 💬
1675Naproxen[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[4] 13, 46, 107, 271 💬
1676Nasal Methylprednisolone (MT)[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1677NATALIZUMAB[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[5] 13, 15, 25, 46, 96 💬
1678Natalizumab (BG00002)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1679Natalizumab (NTZ)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1680Natalizumab (Tysabri)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1681Natalizumab 300 MG in 15 ML Injection[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1682Natalizumab for IV Infusion[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1683Natalizumab for Subcutaneous Injection[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1684Natalizumab Injection [Tysabri][1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1685Natalizumab IV[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1686Natalizumab SC[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1687Natalizumab treatment[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1688NBI-5788----[1] 13 💬
1689NBT-NM108 (60 g/day)----[1] 13 💬
1690Nd----[6] 2, 6, 13, 46, 51, 97 💬
1691NEBIDO----[1] 13 💬
1692Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection[2] Testosterone,
Testosterone undecanoate		[2] Testosterone ,
Testosterone undecanoate 💬 		[1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 13 💬
1693Necator americanus----[1] 13 💬
1694NeoRecormon[1] Epoetin beta[1] Epoetin beta 💬 [1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[2] 13, 18 💬
1695Neramexane[1] Neramexane---[1] 13 💬
1696Neramexane mesylate[1] Neramexane---[1] 13 💬
1697Nerispirdine[1] Nerispirdine---[1] 13 💬
1698Nerispirdine (HP184)[1] Nerispirdine---[1] 13 💬
1699Nerispirdine hydrochloride[1] Nerispirdine---[1] 13 💬
1700NEUPOGEN----[4] 13, 28, 51, 285 💬
1701NEUROASPIS PLP10®----[1] 13 💬
1702Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV----[1] 13 💬
1703NEURONTIN----[1] 13 💬
1704Neurontin 300 mg hard capsule----[2] 13, 18 💬
1705NEUROSWING Orthosis (experimental) : carbon orthosis with an active ankle articulation----[1] 13 💬
1706NeuroVax[1] NeuroVax---[1] 13 💬
1707NeuroVax 300ug/mL Dose for IM Injection[1] NeuroVax---[1] 13 💬
1708New Formulation of rebif - human interferon beta-1a[2] Human interferon beta,
Interferon beta-1a		[2] Interferon beta ,
Interferon beta-1a 💬 		[2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
1709NG01 - Autologous bone marrow derived human stromal cells----[1] 13 💬
1710Niacinamide----[3] 6, 13, 67 💬
1711Nicotinamid riboside----[1] 13 💬
1712NICOTINE[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[3] 6, 13, 84 💬
1713Nintendo Wii Fit Balance Board----[1] 13 💬
1714NIRS after bosentan administration[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
1715NIRS baseline----[1] 13 💬
1716Nitrofurantoin[1] Nitrofurantoin[1] Nitrofurantoin 💬 --[1] 13 💬
1717Nivolumab[1] Nivolumab[1] Nivolumab 💬 [1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
1718NK042----[1] 13 💬
1719NLY01----[2] 6, 13 💬
1720Nomegestrol[1] Nomegestrol[1] Nomegestrol 💬 [1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
1721Nomegestrol acetate[3] Acetate,
Nomegestrol,
Nomegestrol acetate		[2] Nomegestrol ,
Nomegestrol acetate 💬 		[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
1722Non disponibile----[2] 13, 201 💬
1723Non-pegylated interferon----[1] 13 💬
1724None----[14] 13, 46, 65, 84, 85, 96, 97, 106, 160, 161, 171, 222, 223, 299 💬
1725Norethindrone----[2] 13, 49 💬
1726Normal Saline----[20] 6, 13, 17, 22, 36, 46, 49, 60, 70, 71, 79, 94, 96, 97, 210, 211, 226, 276, 296, 299 💬
1727Normal Saline for Injection----[1] 13 💬
1728NOVANTRONE*INF 2MG/ML 5ML----[1] 13 💬
1729Novartis Pharmaceuticals Corporation----[1] 13 💬
1730NOVATREX----[1] 13 💬
1731NPB-01----[3] 13, 14, 162 💬
1732NT-KO-003----[1] 13 💬
1733NU100----[1] 13 💬
1734NurOwn (MSC-NTF cells)----[2] 2, 13 💬
1735NVF233----[1] 13 💬
1736Obecabtagene autoleucel[1] Obecabtagene autoleucel[1] Obecabtagene autoleucel 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[2] 13, 49 💬
1737Obecabtagene autoleucel (obe-cel)[1] Obecabtagene autoleucel[1] Obecabtagene autoleucel 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[2] 13, 49 💬
1738Obexelimab[1] Obexelimab[1] Obexelimab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[4] 13, 49, 61, 300 💬
1739OCH-NCNP1----[1] 13 💬
1740Oclelizumab----[1] 13 💬
1741OCR----[1] 13 💬
1742OCR SC----[1] 13 💬
1743Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[4] 11, 13, 46, 49 💬
1744Ocrelizumab (CinnaGen, Iran)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1745Ocrelizumab (EU)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1746Ocrelizumab (Roche, Switzerland)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1747Ocrelizumab (US)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1748Ocrelizumab 300 mg[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1749Ocrelizumab 300mg[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1750Ocrelizumab 300mg /10ml[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1751Ocrelizumab 300mg/10 ml[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1752Ocrelizumab 300mg/10ml[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1753Ocrelizumab 600 mg[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1754Ocrelizumab at home[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1755Ocrelizumab co-formulated with rHuPH20[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1756Ocrelizumab Dose 1[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1757Ocrelizumab Dose 2 and Dose 3[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1758Ocrelizumab Injection [Ocrevus][1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1759Ocrelizumab IV[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1760Ocrelizumab Reference Formulation[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1761Ocrelizumab SC[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1762Ocrelizumab Test Formulation[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1763OCREVUS----[1] 13 💬
1764Ocrevus 300 mg, solution à diluer pour perfusion----[1] 13 💬
1765Ocrevus-EU----[1] 13 💬
1766Ocrevus-US----[1] 13 💬
1767OcrevusPharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: OcrelizumabCAS Number: 637334-45-3Current Sponsor code: RO4964913Other descriptive name: OCRELIZUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous useTrade Name: GilenyaPharmaceutical Form: Capsule, hardINN or Proposed INN: FingolimodCAS Number: 162359-55-9Current Sponsor code: RO7079904Other descriptive name: FINGOLIMODConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.5-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use----[1] 13 💬
1768Ocrevus®----[1] 13 💬
1769Ocrrelizumab 300 mg----[1] 13 💬
1770Octagam----[2] 13, 65 💬
1771Octagam 5%----[2] 13, 65 💬
1772Octagam 50 mg/ml----[1] 13 💬
1773Ocufolin----[1] 13 💬
1774Ofatumumab[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[6] 11, 13, 35, 46, 222, 223 💬
1775Ofatumumab 100[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1776Ofatumumab 300[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1777Ofatumumab 30mg[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1778Ofatumumab 3mg[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1779Ofatumumab 60mg[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1780Ofatumumab 700[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1781Ofatumumab approved dose[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1782Ofatumumab new dose[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1783Ofatumumab subcutaneous injection[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 13, 35 💬
1784Ofatunumab----[1] 13 💬
1785Oleic Acid[1] Oleic Acid[1] Oleic acid 💬 --[2] 13, 299 💬
1786Oleovit D3 14.400 IU/ml oral drops, solution----[1] 13 💬
1787Olesoxime[1] Olesoxime[1] Olesoxime 💬 --[3] 2, 3, 13 💬
1788Olesoxime (TRO19622)[1] Olesoxime[1] Olesoxime 💬 --[1] 13 💬
1789Olive oil[1] Olive oil[1] Olive oil 💬 --[10] 13, 34, 35, 46, 49, 53, 97, 124, 162, 271 💬
1790OMB157----[1] 13 💬
1791OMB157G----[1] 13 💬
1792Omega 3 fatty acids----[1] 13 💬
1793Omega-3 fatty acids[1] Omega-3 fatty acids---[4] 13, 49, 79, 223 💬
1794Omeprazole[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[18] 6, 8, 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
1795OnabotulinumtoxinA----[2] 6, 13 💬
1796ONO-4641----[1] 13 💬
1797ONO-4641/ MSC2430913A----[1] 13 💬
1798ONO-4641/MSC2430913A----[1] 13 💬
1799Opicinumab[1] Opicinumab[1] Opicinumab 💬 --[1] 13 💬
1800Oral corticosteroids----[4] 13, 46, 97, 251 💬
1801Oral Glucocorticoids----[1] 13 💬
1802Oral immunosuppressant----[1] 13 💬
1803Oral lipoic acid (LA)[1] Lipoic acid[1] Thioctic acid 💬 --[1] 13 💬
1804Oral Methylprednisolone 625 mg/24h x3 days[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1805Oral THC----[1] 13 💬
1806Orca-Q----[1] 13 💬
1807Orelabrutinib[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[5] 13, 49, 53, 61, 63 💬
1808ORY2001----[1] 13 💬
1809OS440----[1] 13 💬
1810Other analgesics and antipyretics----[1] 13 💬
1811Other disease-modifying therapy----[1] 13 💬
1812Other H1 antagonist----[1] 13 💬
1813OTHER NERVOUS SYSTEM DRUGS----[2] 6, 13 💬
1814Other treatment----[1] 13 💬
1815Other: Aerobic training----[1] 13 💬
1816Other: analysis of blood samples----[1] 13 💬
1817Other: Antral follicle count (AFC)----[1] 13 💬
1818Other: anxiety----[1] 13 💬
1819Other: At-home natalizumab treated MS patient[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1820Other: Autologous hematopoietic stem cell transplantation----[1] 13 💬
1821Other: Autologous peripheral blood differentiated adult tolerogenic dendritic cells expanded----[1] 13 💬
1822Other: Balance----[3] 6, 13, 299 💬
1823Other: balance based torso weighting----[1] 13 💬
1824Other: Balance exercise program using exoskeleton device----[1] 13 💬
1825Other: Balance Exercises----[1] 13 💬
1826Other: Balance Exercises with Stroboscopic Glasses----[1] 13 💬
1827Other: Balance exercises with Virtual Reality Glasses----[1] 13 💬
1828Other: Balance Exercises with Visual-Based Metaphor Training----[1] 13 💬
1829Other: Balance Trainer Balance Exercises----[1] 13 💬
1830Other: Balance Training----[2] 6, 13 💬
1831Other: Balance training only----[1] 13 💬
1832Other: Balance training wiith combined neuromodulation (TSCS+FES)----[1] 13 💬
1833Other: Balance training with FES----[1] 13 💬
1834Other: Berg Balance Scale----[3] 6, 13, 149 💬
1835Other: Blood draw----[17] 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
1836Other: Blood draw for future biomarker analysis----[2] 13, 63 💬
1837Other: Blood Flow Restriction----[1] 13 💬
1838Other: Blood Flow Restriction Exercise----[1] 13 💬
1839Other: Blood Flow Restriction training with Oclussion Cuff.----[1] 13 💬
1840Other: Blood sample----[37] 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
1841Other: Blood Sample Collection----[5] 6, 13, 51, 57, 58 💬
1842Other: Blood sample taken at a single time point----[3] 13, 46, 49 💬
1843Other: Blood Samples----[13] 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
1844Other: Blood samples for PK----[1] 13 💬
1845Other: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19----[1] 13 💬
1846Other: Blood sampling----[14] 6, 13, 19, 46, 49, 51, 53, 58, 67, 127, 222, 266, 296, 299 💬
1847Other: Blood sampling (controls)----[1] 13 💬
1848Other: Blood sampling (MS)----[1] 13 💬
1849Other: Blood Test 1----[1] 13 💬
1850Other: Blood Test 2----[1] 13 💬
1851Other: Blood tests----[1] 13 💬
1852Other: Blood withdrawal----[1] 13 💬
1853Other: Brain MRI----[2] 13, 127 💬
1854Other: Caffeine[1] Caffeine[2] Caffeine ,
Caffeine citrate 💬 		[11] ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		[22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
1855Other: Cardiopulmonary evaluation----[1] 13 💬
1856Other: Cawthorne Cooksey exercises----[1] 13 💬
1857Other: Cheek swab----[2] 11, 13 💬
1858Other: Classic, progressive endurance training----[1] 13 💬
1859Other: clinical and neurological evaluation----[1] 13 💬
1860Other: Clinical assessment----[1] 13 💬
1861Other: CoDuSe balance training and step square exercises----[1] 13 💬
1862Other: Cognitive Rehabilitation:----[1] 13 💬
1863Other: Combined Otago-Based and Game-Inspired Balance Training----[1] 13 💬
1864Other: conventional balance training----[1] 13 💬
1865Other: Core stability----[1] 13 💬
1866Other: Covid-19 vaccine----[1] 13 💬
1867Other: CSF Sampling----[1] 13 💬
1868Other: Dalfampridine plus physical therapy[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
1869Other: data collection----[2] 13, 299 💬
1870Other: Determination of calcium intake by a dietician interview[1] Calcium---[2] 13, 46 💬
1871Other: dimethyl fumarate (DMF)[1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[1] 13 💬
1872Other: diroximel fumarate (DRF)[1] Diroximel fumarate[1] Diroximel fumarate 💬 --[1] 13 💬
1873Other: Disability evaluation tests----[1] 13 💬
1874Other: DMT category 1----[1] 13 💬
1875Other: DMT withdrawal----[1] 13 💬
1876Other: Dual Task Performance----[1] 13 💬
1877Other: Dynamic Balance Training----[1] 13 💬
1878Other: Dynamic balance walking training----[1] 13 💬
1879Other: Essential Oil Blend (Lavender, Rosemary)[1] Rosemary---[1] 13 💬
1880Other: Evaluation of degree chronic fatigue.----[1] 13 💬
1881Other: Evaluation of lower extremity muscle strength, physical activity, exercise capacity, balance, quality of life, and fatigue in healthy controls----[1] 13 💬
1882Other: Evaluation of lower extremity muscle strength, physical activity, exercise capacity, balance, quality of life, and fatigue in POMS----[1] 13 💬
1883Other: Exercise intervention----[3] 13, 18, 60 💬
1884Other: Exposure to methylprednisolone during pregnancy[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1885Other: fatigue----[1] 13 💬
1886Other: Fear of falling----[1] 13 💬
1887Other: Fecal Microbiota Transplantation (FMT)[1] Fecal microbiota---[2] 13, 97 💬
1888Other: Four Square Step Test----[2] 6, 13 💬
1889Other: Functional mobility----[2] 6, 13 💬
1890Other: Functional Reach Test----[2] 6, 13 💬
1891Other: glatiramer acetate[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1892Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod[7] Acetate,
Fingolimod,
Glatiramer,
Ozanimod,
Ponesimod,
Siponimod,
Teriflunomide		[10] Fingolimod hydrochloride ,
Glatiramer acetate ,
Fingolimod ,
Teriflunomide ,
Ozanimod hydrochloride ,
Ozanimod ,
Siponimod fumarate ,
Ponesimod ,
Siponimod ,
Fingolimod lauryl sulfate 💬 		[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[37] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1893Other: Group balance training----[1] 13 💬
1894Other: Gustatory sensitivity test using Taste strips----[1] 13 💬
1895Other: Histamine[1] Histamine[3] Histamine dihydrochloride ,
Histamine phosphate ,
Histamine 💬 		[4] HRH1,
HRH2,
HRH3,
HRH4 💬 		[5] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
1896Other: Hydrogen peroxide[2] Hydrogen,
Hydrogen peroxide		[1] Hydrogen peroxide 💬 --[1] 13 💬
1897Other: Imaging----[1] 13 💬
1898Other: Incontinence Severity----[1] 13 💬
1899Other: Inspiratory Muscle Training----[1] 13 💬
1900Other: interferon beta1----[1] 13 💬
1901Other: interferon ß1----[1] 13 💬
1902Other: Intrathecal saline injection----[1] 13 💬
1903Other: IV Methylprednisolone administration[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1904Other: Laboratory Biomarker Analysis----[22] 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
1905Other: Liberation therapy----[1] 13 💬
1906Other: Low-Load Exercise Control Group----[1] 13 💬
1907Other: Low-Load Exercise with Blood Flow Restriction----[1] 13 💬
1908Other: Magnetic Resonance Imaging----[2] 13, 15 💬
1909Other: Medication Diary----[1] 13 💬
1910Other: mitoxantrone - immunomodulator[1] Mitoxantrone[2] Mitoxantrone hydrochloride ,
Mitoxantrone 💬 		--[1] 13 💬
1911Other: Modified paleolithic diet----[1] 13 💬
1912Other: Motor Imagery as compared to physical practice for balance tasks----[1] 13 💬
1913Other: MRI----[4] 3, 13, 127, 206 💬
1914Other: MSCs----[1] 13 💬
1915Other: Multiple Sclerosis patients who have been on Ocrelizumab will undergo cognitive and fatigue assessments[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1916Other: myBETAapp----[1] 13 💬
1917Other: Natalizumab[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1918Other: Natalizumab discontinuation[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1919Other: Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq[8] Alemtuzumab,
Cladribine,
Hyaluronidase,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Rituximab,
Ublituximab		[10] Cladribine ,
Alemtuzumab ,
Rituximab ,
Hyaluronidase ,
Hyaluronidase ,
Ocrelizumab ,
Hyaluronidase ,
Natalizumab ,
Ofatumumab ,
Ublituximab 💬 		[3] ITGA4,
MS4A1,
RRM1 💬 		[21] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Focal adhesion, Glutathione metabolism, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1920Other: NBT-NM108 (0 g/day)----[1] 13 💬
1921Other: Neurocognitive examination for healthy subjects----[1] 13 💬
1922Other: Neurologic / neuropsychologic tests - Controls----[1] 13 💬
1923Other: Neurologic / neuropsychologic tests - Patients----[1] 13 💬
1924Other: Neuromuscular evaluation----[1] 13 💬
1925Other: Neuropsychological tests----[1] 13 💬
1926Other: Neutral Carrier Oil (Apricot Kernel Oil)[2] Apricot,
Apricot kernel oil		---[1] 13 💬
1927Other: Nintendo Wii Fit Balance exercises----[1] 13 💬
1928Other: No intervention, just collect blood samples and CSF samples----[1] 13 💬
1929Other: No MSDMDs therapy (control)----[1] 13 💬
1930Other: No study treatments administered - blood draws only----[1] 13 💬
1931Other: No Treatment Arm----[1] 13 💬
1932Other: normal saline----[5] 13, 97, 222, 226, 280 💬
1933Other: Observation of Ocrelizumab as Treatment in RRMS Patients[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1934Other: Observational Control----[1] 13 💬
1935Other: Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1936Other: Ofatumumab[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1937Other: One-leg Stance Test----[1] 13 💬
1938Other: Otago Exercise Program only----[1] 13 💬
1939Other: Other disease modifying therapies----[1] 13 💬
1940Other: Other: Disease modifying therapies (DMT)----[1] 13 💬
1941Other: pain----[1] 13 💬
1942Other: PEAK----[1] 13 💬
1943Other: Peanut Butter[1] Peanut---[1] 13 💬
1944Other: Periodized exercise training----[1] 13 💬
1945Other: PK microsampling of blood----[4] 6, 8, 13, 97 💬
1946Other: plasticity-based computerized cognitive remediation program----[1] 13 💬
1947Other: PNF----[1] 13 💬
1948Other: Position Sense----[1] 13 💬
1949Other: Progressive exercise----[1] 13 💬
1950Other: propensity score----[1] 13 💬
1951Other: PSP----[1] 13 💬
1952Other: QALCIMUM questionnaire----[2] 13, 46 💬
1953Other: Questionnaires----[8] 3, 6, 13, 41, 46, 77, 96, 226 💬
1954Other: Registry----[4] 6, 8, 13, 97 💬
1955Other: SF-12 questionnaire----[3] 13, 51, 56 💬
1956Other: Siponimod[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1957Other: Sodium Chloride 0.9%[1] Sodium chloride[1] Sodium chloride 💬 --[1] 13 💬
1958Other: specifically design 6 month resistance training program----[1] 13 💬
1959Other: Spinning grp----[1] 13 💬
1960Other: Standard medical treatment----[6] 13, 96, 97, 149, 153, 171 💬
1961Other: Standard of Care----[11] 13, 49, 57, 64, 79, 85, 95, 96, 97, 245, 246 💬
1962Other: Static Balance Test----[1] 13 💬
1963Other: Strength training----[1] 13 💬
1964Other: Supervised physical therapy----[1] 13 💬
1965Other: teriflunomide[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 13 💬
1966Other: Timed Up an Go Test----[1] 13 💬
1967Other: Traditional Balance Exercises----[1] 13 💬
1968Other: Training groupe----[1] 13 💬
1969Other: Trunk impairment----[1] 13 💬
1970Other: Trunk position sense----[1] 13 💬
1971Other: USPIO MRI - Gadolinium MRI[1] Gadolinium---[1] 13 💬
1972Other: Usual Care----[4] 13, 46, 107, 299 💬
1973Other: Venous blood draw and skin biopsy----[2] 2, 13 💬
1974Other: Vestibular habituation exercises----[1] 13 💬
1975Other: Vestibular rehabilitation: balance and eye movement exercises----[1] 13 💬
1976Other: Virtual reality group----[1] 13 💬
1977Other: Vitamin K----[1] 13 💬
1978Other: Vitamin K Cream----[1] 13 💬
1979Other: Withdrawal of dalfampridine-ER 10mg[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
1980Ovastat 1000[1] Treosulfan[1] Treosulfan 💬 --[2] 13, 65 💬
1981Ovastat 5000[1] Treosulfan[1] Treosulfan 💬 --[2] 13, 65 💬
1982Oxcarbazepine[1] Oxcarbazepine[1] Oxcarbazepine 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 13 💬
1983Oxiklorin----[2] 13, 46 💬
1984Oxybutynin[1] Oxybutynin[2] Oxybutynin ,
Oxybutynin chloride 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[3] 6, 13, 53 💬
1985Oxybutynin hydrochloride[1] Oxybutynin[2] Oxybutynin ,
Oxybutynin chloride 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[2] 6, 13 💬
1986Oxycodone[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[7] 6, 13, 46, 70, 226, 231, 298 💬
1987Oxygen[1] Oxygen[1] Oxygen 💬 --[30] 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
1988Ozanimod[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 96, 97 💬
1989Ozanimod 0.5 mg[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1990Ozanimod 1 mg[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1991Ozanimod Cloridrato[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1992Ozanimod HCI[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1993Ozanimod HCL[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 96, 97 💬
1994Ozanimod hydrochloride[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 96, 97 💬
1995Ozanimod Oral Capsule[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 97 💬
1996P-CD19CD20-ALLO1 Cells----[2] 13, 49 💬
1997Palifermin[1] Palifermin[1] Palifermin 💬 [1] FGFR2 💬 [12] Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[6] 13, 36, 38, 39, 65, 96 💬
1998Pantoprazole[1] Pantoprazole[2] Pantoprazole sodium ,
Pantoprazole 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[2] 13, 65 💬
1999PARACETAMOL----[6] 3, 6, 13, 28, 46, 48 💬
2000Paracetamolo 500 mg----[1] 13 💬
2001Paroxetine[1] Paroxetine[4] Paroxetine hydrochloride hemihydrate ,
Paroxetine ,
Paroxetine hydrochloride ,
Paroxetine mesylate 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[4] 6, 13, 46, 85 💬
2002Part A: 100 mg/mL GSK2618960----[1] 13 💬
2003Part B: Dose of GSK2618960 decided from Part A----[1] 13 💬
2004Part C: Dose of GSK2618960 decided from Part A and B----[1] 13 💬
2005PB006----[1] 13 💬
2006PB018----[1] 13 💬
2007Peanut[1] Peanut---[1] 13 💬
2008PEG-liposomal Prednisolone Sodium Phosphate[2] Prednisolone,
Prednisolone phosphate		[2] Prednisolone ,
Prednisolone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 97 💬
2009PEGINTERFERON BETA-1A[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2010Peginterferone beta 1a----[1] 13 💬
2011PEGINTERFERONE BETA-1A----[1] 13 💬
2012PEGINTERFERONE LAMBDA-1A----[1] 13 💬
2013PEGylated Intereron Beta-1a----[1] 13 💬
2014PEGylated Interferon Beta-1a[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2015Pending----[7] 6, 13, 19, 96, 97, 113, 302 💬
2016Peptid coupled red blood cells----[1] 13 💬
2017Peptide coupled red blood cells----[1] 13 💬
2018Perfusion of treatment Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2019Perfusion of treatment Rituximab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2020Peripheral Blood Stem Cell Transplantation----[12] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
2021Peripheral blood withdrawal----[1] 13 💬
2022Personalized extended interval dosing of natalizumab[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
2023Pertussis vaccine[1] Pertussis vaccine[1] Pertussis vaccine 💬 --[2] 13, 46 💬
2024PET with 11C-Flumazenil[1] Flumazenil[1] Flumazenil 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13 💬
2025PF-06342674 0.25 mg/kg----[1] 13 💬
2026PF-06342674 1.5 mg/kg----[1] 13 💬
2027PF-06342674 6.0 mg/kg----[1] 13 💬
2028Phase 2----[1] 13 💬
2029Phase 3----[1] 13 💬
2030PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR[1] Lysine[4] Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--[1] 13 💬
2031Phenytoin[1] Phenytoin[2] Phenytoin ,
Phenytoin sodium 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 13 💬
2032PI-2301----[1] 13 💬
2033Pioglitazone[1] Pioglitazone[2] Pioglitazone hydrochloride ,
Pioglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
2034PIPE-307----[1] 13 💬
2035PIPE-307 Dose A----[1] 13 💬
2036PIPE-307 Dose B----[1] 13 💬
2037PIPE-791----[2] 13, 85 💬
2038Pirfenidone[1] Pirfenidone[1] Pirfenidone 💬 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		[83] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[12] 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2039Pirtobrutinib[1] Pirtobrutinib[1] Pirtobrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 13, 63 💬
2040Pittsburgh Compound B[1] Pittsburgh Compound B---[3] 6, 13, 127 💬
2041PIXANTRONE[1] Pixantrone[2] Pixantrone ,
Pixantrone dimaleate 💬 		--[2] 11, 13 💬
2042PL 04515/0127----[1] 13 💬
2043PL 12762/0049----[1] 13 💬
2044Plasma exchange----[7] 13, 43, 44, 64, 95, 171, 222 💬
2045Plasma exchange (PE)----[6] 11, 13, 64, 66, 221, 223 💬
2046Platelet transfusion----[1] 13 💬
2047Platform----[1] 13 💬
2048Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons)[4] Acetate,
Dimethyl fumarate,
Glatiramer,
Teriflunomide		[3] Dimethyl fumarate ,
Glatiramer acetate ,
Teriflunomide 💬 		[22] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
KEAP1 💬 		[39] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Parkinson disease, Pathways in cancer, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
2049Platinum[1] Platinum---[8] 13, 46, 49, 50, 51, 53, 96, 97 💬
2050Platinum Compound[1] Platinum---[8] 13, 46, 49, 50, 51, 53, 96, 97 💬
2051Platinum Doublet[1] Platinum---[8] 13, 46, 49, 50, 51, 53, 96, 97 💬
2052PLEDIGRY----[1] 13 💬
2053Plegridy----[1] 13 💬
2054Plegridy (Peg IFNbeta-1-a, Biogen Netherlands B.V)----[1] 13 💬
2055Plegridy (Peg IFNß-1-a, Biogen Netherlands B.V)----[1] 13 💬
2056Plegridy (peginterferon beta-1a), Biogen Idec Ltd[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2057PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE----[1] 13 💬
2058Plegridy 125 micrograms----[1] 13 💬
2059Plegridy 63 micrograms----[1] 13 💬
2060Pleneva TM BGC20-0134----[1] 13 💬
2061Plovamer acetate[1] Acetate---[1] 13 💬
2062Plovamer acetate 0.5 milligram (mg)[1] Acetate---[1] 13 💬
2063Plovamer acetate 10 mg[1] Acetate---[1] 13 💬
2064Plovamer acetate 20 mg[1] Acetate---[1] 13 💬
2065Plovamer acetate 3 mg[1] Acetate---[1] 13 💬
2066PLP peptide----[1] 13 💬
2067PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----[2] 13, 14 💬
2068Pneumococcal polysaccharide vaccine----[3] 13, 46, 223 💬
2069Pneumovax II----[1] 13 💬
2070PNU-215062 sodium salt----[1] 13 💬
2071PO----[1] 13 💬
2072Polyphenon E----[2] 13, 36 💬
2073PONESIMOD[1] Ponesimod[1] Ponesimod 💬 [1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2074Ponesimod 10 mg[1] Ponesimod[1] Ponesimod 💬 [1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2075Ponesimod 20 mg[1] Ponesimod[1] Ponesimod 💬 [1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2076Ponesimod 40 mg[1] Ponesimod[1] Ponesimod 💬 [1] S1PR1 💬 [4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2077PonesimodProduct Code: JNJ-67896153/ACT-128800Pharmaceutical Form: Film-coated tabletINN or Proposed INN: PonesimodCAS Number: 854107-55-4Current Sponsor code: JNJ-67896153Other descriptive name: ACT-128800Concentration unit: mg milligram(s)Concentration type: up toConcentration number: 20-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 13 💬
2078Ponvory----[1] 13 💬
2079Pravastatin[1] Pravastatin[2] Pravastatin sodium ,
Pravastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬
2080PRD806998----[1] 13 💬
2081Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)----[1] 13 💬
2082Prebiotics and Probiotics supplementation----[1] 13 💬
2083PREDNISOLONE[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[48] 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
2084PREDNISOLONE SODIUM PHOSPHATE[2] Prednisolone,
Prednisolone phosphate		[2] Prednisolone ,
Prednisolone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 3, 13, 97 💬
2085Prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[58] 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
2086Pregabalin[1] Pregabalin[1] Pregabalin 💬 [4] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬 		[7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬[5] 13, 36, 46, 70, 298 💬
2087Prepulsid----[1] 13 💬
2088Prevenar 13----[5] 13, 46, 96, 97, 223 💬
2089PRN2246----[2] 11, 13 💬
2090Probiotic----[10] 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
2091Probiotic dietary supplement----[1] 13 💬
2092Probiotics (Visbiome®)----[1] 13 💬
2093Procedure/Surgery: Implant Procedure----[1] 13 💬
2094Prohance (Gadoteridol)[1] Gadoteridol[1] Gadoteridol 💬 --[1] 13 💬
2095Prolonged-release Fampridine----[1] 13 💬
2096Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)----[1] 13 💬
2097Propionic acid 1000 mg capsule----[1] 13 💬
2098Protein A immunoadsorption----[1] 13 💬
2099Provigil----[1] 13 💬
2100Provigil (modafinil)[1] Modafinil[1] Modafinil 💬 --[1] 13 💬
2101PRUCALOPRIDE[1] Prucalopride[2] Prucalopride ,
Prucalopride succinate 💬 		[1] HTR4 💬 [5] Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[3] 13, 51, 96 💬
2102Psilocybin[1] Psilocybin[1] Psilocybin 💬 [1] HTR2A 💬 [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[5] 2, 6, 13, 149, 206 💬
2103Psilocybin therapy[1] Psilocybin[1] Psilocybin 💬 [1] HTR2A 💬 [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[3] 2, 6, 13 💬
2104PTL201----[1] 13 💬
2105QT-019C----[5] 11, 13, 49, 51, 63 💬
2106Quadrivalent influenza vaccine----[1] 13 💬
2107Quality of life----[1] 13 💬
2108Quercetin[1] Quercetin---[10] 13, 46, 65, 84, 85, 97, 192, 271, 285, 299 💬
2109Quetiapine[1] Quetiapine[2] Quetiapine fumarate ,
Quetiapine 💬 		[2] DRD2,
HTR2A 💬 		[13] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬[2] 6, 13 💬
2110Quinidina sulfato----[1] 13 💬
2111Quinidine[1] Quinidine[4] Quinidine gluconate ,
Quinidine polygalacturonate ,
Quinidine sulfate ,
Quinidine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[3] 2, 8, 13 💬
2112Quinidine Sulfate[1] Quinidine[4] Quinidine gluconate ,
Quinidine polygalacturonate ,
Quinidine sulfate ,
Quinidine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 13 💬
2113R lipoic acid[1] Lipoic acid[1] Thioctic acid 💬 --[1] 13 💬
2114RA15804589, C19061501-F, DNL788, DN2489, DN0002489----[2] 2, 13 💬
2115Rabbit[1] Rabbit---[11] 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
2116Rabbit anti-human thymocyte immunoglobulin[1] Rabbit---[2] 13, 96 💬
2117RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN[1] Rabbit---[2] 13, 60 💬
2118Radiation therapy----[3] 13, 284, 285 💬
2119Radiation: Gadopentetate Dimeglumine[1] Gadopentetic acid[2] Gadopentetate dimeglumine ,
Gadopentetic acid 💬 		--[2] 13, 34 💬
2120Radiation: Radiotracer [11C]-CS1P1----[1] 13 💬
2121Radiation: Radiotracer [11C]-DPA-713----[1] 13 💬
2122Radiation: Radiotracer [12F]-FDG----[1] 13 💬
2123Ralenova----[1] 13 💬
2124Raltegravir[1] Raltegravir[2] Raltegravir ,
Raltegravir potassium 💬 		--[4] 13, 26, 93, 265 💬
2125Ramatroban[1] Ramatroban[1] Ramatroban 💬 [2] PTGDR,
TBXA2R 💬 		[3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬[1] 13 💬
2126Ranitidine[1] Ranitidine[3] Ranitidine ,
Ranitidine hydrochloride ,
Ranitidine bismuth citrate 💬 		[1] HRH2 💬 [4] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[2] 13, 65 💬
2127Rapcabtagene autoleucel (YTB323)----[1] 13 💬
2128Rapid-tapering glucocorticoids + Inebilizumab[1] Inebilizumab[1] Inebilizumab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[1] 13 💬
2129Raptiva 100 mg/ml powder and solvent for solution for injection----[9] 11, 13, 46, 48, 53, 61, 95, 96, 221 💬
2130RATG----[2] 13, 51 💬
2131RAVULIZUMAB[1] Ravulizumab[1] Ravulizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 2, 11, 13, 50, 62, 66, 109, 224 💬
2132RC18 160 mg----[2] 13, 53 💬
2133RC18 160mg----[3] 11, 13, 66 💬
2134RC18 240mg----[2] 13, 66 💬
2135RD06-05 CART Cell Injection----[3] 13, 51, 223 💬
2136REBIF----[1] 13 💬
2137Rebif (IFN beta-1a subcutaneous three times per week)----[1] 13 💬
2138Rebif (IFN ß-1a subcutaneous three times per week)----[1] 13 💬
2139Rebif (IFNbeta-1-a, Merck Europe B.V.)----[1] 13 💬
2140Rebif (IFNß-1-a, Merck Europe B.V.)----[1] 13 💬
2141Rebif (interferon beta 1a)----[1] 13 💬
2142Rebif (Interferon beta-1a)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2143Rebif (interferon beta-1a), Merck Serono Europe Ltd[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2144REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE----[1] 13 💬
2145Rebif 22----[1] 13 💬
2146Rebif 22 micrograms----[1] 13 💬
2147Rebif 22 y 44 mcg----[1] 13 💬
2148Rebif 22®----[1] 13 💬
2149Rebif 44----[1] 13 💬
2150Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia----[1] 13 💬
2151REBIF 44 microgramos solución inyectable----[1] 13 💬
2152REBIF 44 microgramos solución inyectable en jeringa precargada----[1] 13 💬
2153Rebif 44 micrograms----[1] 13 💬
2154Rebif 44 micrograms solution for injection----[1] 13 💬
2155Rebif 44 micrograms solution for injection in pre-filled syringe----[1] 13 💬
2156Rebif 44 µg----[1] 13 💬
2157Rebif 44®----[1] 13 💬
2158Rebif 8,8 µg, Rebif 22µg----[1] 13 💬
2159Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack----[1] 13 💬
2160Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.----[1] 13 💬
2161Rebif New Formulation + ibuprofen PRN[1] Ibuprofen[5] Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
2162Rebif New Formulation + prophylactic Ibuprofen[1] Ibuprofen[5] Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
2163Rebif New Formulation 44mcg multidose cartridge----[1] 13 💬
2164Rebif New Formulation Non Titrated----[1] 13 💬
2165Rebif New Formulation Titrated----[1] 13 💬
2166REBIF SC 12SIR 12000000UI44MCG----[1] 13 💬
2167REBIF SC 12SIR 6000000UI 22MCG----[1] 13 💬
2168REBIF*SC 12SIR 12000000UI44MCG----[1] 13 💬
2169REBIF*SC 12SIR 6000000UI 22MCG----[1] 13 💬
2170Rebif®----[1] 13 💬
2171Rebif® (clone 484-39)----[1] 13 💬
2172Rebif® New Formulation----[1] 13 💬
2173Rebif® New Formulation (IFN-beta-1a, RNF)----[1] 13 💬
2174Rebif® new formulation (RNF)----[1] 13 💬
2175Rebif® New Formulation (RNF) using RebiSmartTM----[1] 13 💬
2176Recombinant human alpha B-crystallin----[1] 13 💬
2177Recombinant Human Erythropoietin[1] Erythropoietin[4] Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 13 💬
2178Recombinant human IFN beta----[1] 13 💬
2179Recombinant human interferon beta[1] Human interferon beta[1] Interferon beta 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2180Recombinant humanized anti-alpha 4 integrin antibody----[1] 13 💬
2181Recombinant humanized anti-CD20 monoclonal antibody----[1] 13 💬
2182RECOMBINANT INTERFERON BE----[1] 13 💬
2183RECOMBINANT INTERFERON BETA-1B[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2184RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN----[2] 11, 13 💬
2185Recombinant zoster vaccine----[2] 13, 49 💬
2186Remibrutinib[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[3] 11, 13, 53 💬
2187Remibrutinib (Blinded)[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
2188Remibrutinib (Open Label)[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
2189Remibrutinib oral treatment[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬
2190Repository corticotropin injection[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 2, 13, 46, 84, 222 💬
2191REVAXIS----[1] 13 💬
2192Rex robotic assisted balance exercises----[1] 13 💬
2193RG2077 (CTLA4-IgG4m)----[1] 13 💬
2194RHB-104----[2] 13, 96 💬
2195RhEPO[1] Erythropoietin[4] Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 13 💬
2196RhIFN beta-1b----[1] 13 💬
2197RhIGF-1 (CEP-151)----[1] 13 💬
2198RHIgM22----[1] 13 💬
2199RhuMab 2H7[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 13, 46, 49 💬
2200RhumAb to Il-17A (IgG1-k-class)----[4] 13, 46, 56, 96 💬
2201RhumAb to IL-17A igG1-k-class----[1] 13 💬
2202RHuPH20----[2] 13, 14 💬
2203Riboflavin[1] Riboflavin[1] Riboflavin 💬 --[8] 13, 38, 46, 96, 97, 162, 168, 265 💬
2204Rifampicin[1] Rifampin[2] Rifampin ,
Rifampicin sodium 💬 		--[6] 6, 13, 17, 46, 93, 299 💬
2205Rifampin[1] Rifampin[2] Rifampin ,
Rifampicin sodium 💬 		--[5] 6, 13, 84, 86, 299 💬
2206RILUTEK----[3] 2, 13, 203 💬
2207RILUZOLE[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[9] 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
2208RIPK1 inhibitor----[1] 13 💬
2209Ritalin----[2] 6, 13 💬
2210Ritalin LA 20mg capsules----[1] 13 💬
2211Ritalin LA 30mg capsules----[1] 13 💬
2212Ritalin LA 40mg capsules----[1] 13 💬
2213RITUXIMAB[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[54] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
2214Rituximab (R)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 13, 43, 44 💬
2215Rituximab Infusion[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 13, 222, 223 💬
2216Rituximab IT[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2217Rituximab IV[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2218Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2219Rituximab(RTX)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2220Rivastigmin----[1] 13 💬
2221RIVASTIGMINE[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[3] 5, 6, 13 💬
2222Rivastigmine transdermal patch[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[2] 6, 13 💬
2223Rixathon----[3] 13, 46, 49 💬
2224RNF----[1] 13 💬
2225RNS60----[2] 2, 13 💬
2226RNS60 125 ml----[1] 13 💬
2227RNS60 250 ml----[1] 13 💬
2228Ro 496-4913/F03----[2] 13, 46 💬
2229Ro 496-4913/F07----[1] 13 💬
2230Ro 533-3787/F01- 06----[1] 13 💬
2231RO0506997----[2] 13, 46 💬
2232RO4964913----[1] 13 💬
2233RO4964913 F07----[1] 13 💬
2234RO4964913/F03----[1] 13 💬
2235RO4964913/F07----[1] 13 💬
2236RO4964913/F07-01----[1] 13 💬
2237RO5333787----[2] 11, 13 💬
2238RO7010939----[2] 13, 46 💬
2239RO7121932 IV----[1] 13 💬
2240RO7121932 SC----[1] 13 💬
2241RO7268489----[1] 13 💬
2242Rolipram[1] Rolipram[1] Rolipram 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[2] 8, 13 💬
2243Rosemary[1] Rosemary---[5] 13, 46, 51, 97, 271 💬
2244RPC-1063----[1] 13 💬
2245RPC1063----[3] 13, 96, 97 💬
2246RPH-035----[1] 13 💬
2247RTL1000[1] RTL-1000---[1] 13 💬
2248RTL1000 (recombinant T cell receptor ligand)[1] RTL-1000---[1] 13 💬
2249Ruxience----[1] 13 💬
2250Ruxolitinib[1] Ruxolitinib[2] Ruxolitinib ,
Ruxolitinib phosphate 💬 		[2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[7] 13, 15, 50, 60, 65, 228, 331 💬
2251RVP-001----[1] 13 💬
2252RYAH-Medtech Inhaler----[5] 2, 6, 13, 96, 97 💬
2253S-warfarin[1] Warfarin[3] Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		[2] NQO1,
VKORC1 💬 		[5] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 13 💬
2254S103 cells----[1] 13 💬
2255SA237----[1] 13 💬
2256Saline----[12] 2, 6, 13, 17, 18, 53, 67, 77, 86, 97, 168, 299 💬
2257Sapelizumab (p-INN)----[1] 13 💬
2258SAR339658----[2] 13, 97 💬
2259SAR441344----[3] 13, 49, 53 💬
2260SAR441344 IV----[2] 13, 49 💬
2261SAR441344 SC----[2] 13, 49 💬
2262SAR442168----[2] 11, 13 💬
2263SAR442168Pharmaceutical Form: Film-coated tablet----[1] 13 💬
2264SAR443820----[2] 2, 13 💬
2265SARS-COV-2 mRNA Vaccine----[1] 13 💬
2266Sativex----[2] 2, 13 💬
2267SATIVEX - SPRAY PER MUCOSA ORALE 3 FLACONI NEBULIZZATORI CON POMPA DOSATRICE DA 10 ML - 90 EROGAZIONI----[1] 13 💬
2268Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal----[1] 13 💬
2269Sativex Oromucosal Spray----[1] 13 💬
2270Sativex Oromucosal Spray (non-marketed)----[1] 13 💬
2271Sativex®----[1] 13 💬
2272SATRALIZUMAB[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[4] 11, 13, 86, 113 💬
2273Satralizumab (120 mg/PFS with NSD)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2274Satralizumab (120 mg/vial)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2275Satralizumab (120mg/vial)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2276Satralizumab (r-INN)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2277Satralizumab (RO5333787/Enspryng /SA237)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2278Satralizumab (RO5333787/Enspryng/SA237)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2279Satralizumab (RO5333787/SA237)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2280Satralizumab 120 mg[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
2281Satrazlizumab (RO5333787/ Enspryng /SA237)----[1] 13 💬
2282SB-683699----[1] 13 💬
2283SB683699----[1] 13 💬
2284SC interferon beta-1a[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2285SC interferon beta-1b[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2286SC Peginterferon beta-1a[1] Peginterferon beta-1a[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2287SCLEROLYM----[1] 13 💬
2288SCM-010----[1] 13 💬
2289Seasonal influenza vaccine----[2] 13, 46 💬
2290Seasonal Quadrivalent influenza vaccine----[1] 13 💬
2291Second-generation fumaric acid[1] Fumaric acid[1] Fumaric acid 💬 --[1] 13 💬
2292SECUKINUMAB[1] Secukinumab[1] Secukinumab 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
2293See Intervention Description)----[1] 13 💬
2294Select DMTs other than ozanimod[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2295Selenium[1] Selenium---[5] 13, 96, 97, 278, 298 💬
2296Sendoxan----[2] 13, 43 💬
2297Sendoxane----[1] 13 💬
2298Sequential treatment with rituximab and cladribine[2] Cladribine,
Rituximab		[2] Cladribine ,
Rituximab 💬 		[2] MS4A1,
RRM1 💬 		[5] Drug metabolism - other enzymes, Glutathione metabolism, Hematopoietic cell lineage, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
2299Serum containing Avonex----[1] 13 💬
2300Serum Free Avonex----[1] 13 💬
2301SH U 555 C----[1] 13 💬
2302Sham Resonance Device (Inactive Control)----[3] 13, 46, 49 💬
2303Sham Transcranial Direct Current Stimulation (tDCS)----[1] 13 💬
2304Short-course Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2305Silodosin[1] Silodosin[1] Silodosin 💬 [1] ADRA1A 💬 [9] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 6, 13 💬
2306Silodosin 8 mg[1] Silodosin[1] Silodosin 💬 [1] ADRA1A 💬 [9] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 13 💬
2307Silodyx----[1] 13 💬
2308Simethicone[1] Simethicone[1] Simethicone 💬 --[2] 13, 96 💬
2309SimvaHEXAL® 40 mg Filmtabletten----[1] 13 💬
2310Simvastatin[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[22] 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
2311Simvastatin 40 mg film-coated tablets[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
2312Simvastatin Alternova[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
2313Simvastatin in relapsing remitting multiple sclerosis[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
2314Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
2315Simvastatine[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[2] 6, 13 💬
2316Simvastatine Sandoz 40 mg filmomhulde tabletten[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
2317Simvastatine Sandoz 40mg deelbare filmomhulde tabletten[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
2318Single-use autoinjector----[1] 13 💬
2319Single-use autoinjector with a prefilled liquid Avonex syringe----[1] 13 💬
2320Sinvastatina Sandoz 40 mg comprimidos revestidos por película----[1] 13 💬
2321Siponimob----[1] 13 💬
2322SIPONIMOD[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
2323Siponimod 0,25 mg[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2324Siponimod 0.25 mg tablet[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
2325Siponimod 0.5 mg tablet[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
2326Siponimod 1 mg[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2327Siponimod 1 mg tablet[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
2328Siponimod 2 mg[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2329Siponimod 2 mg tablet[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
2330Siponimod fumarato[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2331SIPONIMOD FUMARIC ACID[2] Fumaric acid,
Siponimod		[3] Fumaric acid ,
Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2332Sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[46] 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2333Sivatin 40 mg film-coated tablets----[1] 13 💬
2334Sivelestat[1] Sivelestat[1] Sivelestat 💬 [1] ELANE 💬 [4] Neutrophil extracellular trap formation, Phagocytosis, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬[3] 13, 85, 96 💬
2335Sleep assessment----[1] 13 💬
2336Slow-tapering glucocorticoids + Inebilizumab[1] Inebilizumab[1] Inebilizumab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[1] 13 💬
2337SMderpept----[1] 13 💬
2338Smoked Cannabis----[1] 13 💬
2339Sodium chlorid----[1] 13 💬
2340Sodium chloride[1] Sodium chloride[1] Sodium chloride 💬 --[31] 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
2341Sodium Chloride solution[1] Sodium chloride[1] Sodium chloride 💬 --[4] 11, 13, 51, 228 💬
2342Sodium succinate[1] Succinic acid---[11] 13, 46, 49, 50, 51, 81, 83, 95, 97, 211, 222 💬
2343Solifenacin[1] Solifenacin[2] Solifenacin succinate ,
Solifenacin 💬 		[1] CHRM3 💬 [12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[3] 6, 13, 53 💬
2344Solifenacin Succinate[1] Solifenacin[2] Solifenacin succinate ,
Solifenacin 💬 		[1] CHRM3 💬 [12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[1] 13 💬
2345SOLIRIS----[6] 11, 13, 14, 62, 109, 223 💬
2346SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)----[3] 13, 62, 109 💬
2347Solriamfetol[1] Solriamfetol[2] Solriamfetol ,
Solriamfetol hydrochloride 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
2348SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----[3] 13, 14, 53 💬
2349Solu-Medrol----[5] 13, 51, 53, 97, 211 💬
2350SOLU-MODERIN 1 g----[1] 13 💬
2351SoluMedrol----[3] 13, 46, 107 💬
2352Solumedrol IM 125mg/2ml----[1] 13 💬
2353Somatorelin[1] Somatorelin[1] Somatorelin 💬 [1] GHRHR 💬 [3] Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
2354Somatosensory evoked potential (SSEP)----[1] 13 💬
2355SPARC0921----[1] 13 💬
2356Spikevax----[1] 13 💬
2357Spiropent----[2] 6, 13 💬
2358SR-fampridine----[1] 13 💬
2359Ss-interferon----[1] 13 💬
2360Standard gadolinium contrast[1] Gadolinium---[1] 13 💬
2361Standard interval dosing----[1] 13 💬
2362Standard Lymphodepletion regimen----[3] 11, 13, 51 💬
2363Standard MS DMT----[1] 13 💬
2364Standard MS DMTs----[1] 13 💬
2365Standard of Care----[18] 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
2366Standard treatment with a conventional drug----[1] 13 💬
2367Standard-of-care----[1] 13 💬
2368Standardized cannabis extract----[1] 13 💬
2369Statin----[1] 13 💬
2370Stem Cell Transplantation----[14] 13, 19, 20, 46, 48, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
2371Study Drug----[3] 6, 13, 74 💬
2372SUB0750MIG----[1] 13 💬
2373SUB175614----[1] 13 💬
2374SUB22282----[1] 13 💬
2375Sublingual tizanidine 12 mg[1] Tizanidine[2] Tizanidine hydrochloride ,
Tizanidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
2376Sunflower Oil[1] Sunflower oil[1] Sunflower oil 💬 --[4] 13, 46, 79, 299 💬
2377Sunphenon----[2] 13, 113 💬
2378Sunphenon EGCG----[3] 13, 17, 113 💬
2379Sunphenon EGCg TM----[1] 13 💬
2380Suspension media----[1] 13 💬
2381Sustained-release oral dalfampridine[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
2382Suvorexant[1] Suvorexant[1] Suvorexant 💬 [2] HCRTR1,
HCRTR2 💬 		[2] Hormone signaling, Neuroactive ligand-receptor interaction 💬[3] 5, 6, 13 💬
2383Syngeneic Bone Marrow Transplantation----[3] 11, 13, 14 💬
2384T cell vaccination----[1] 13 💬
2385T-Cell Vaccination----[1] 13 💬
2386T-Detect COVID T-cell blood test----[1] 13 💬
2387Tachipirina----[3] 13, 28, 53 💬
2388TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE----[2] 13, 53 💬
2389TACI-Fc5[1] Atacicept[1] Atacicept 💬 [2] TNFSF13,
TNFSF13B 💬 		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 13, 46, 49 💬
2390Tacrolimus[1] Tacrolimus[2] Tacrolimus ,
Tacrolimus 💬 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[37] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
2391Tamsulosin[1] Tamsulosin[2] Tamsulosin hydrochloride ,
Tamsulosin 💬 		[3] ADRA1A,
ADRA1B,
ADRA1D 💬 		[9] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 13 💬
2392Tarenflurbil[1] Tarenflurbil[1] Tarenflurbil 💬 [4] APH1A,
NCSTN,
PSEN1,
PSENEN 💬 		[7] Alzheimer disease, Cadherin signaling, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Pathways of neurodegeneration - multiple diseases, Wnt signaling pathway 💬[1] 13 💬
2393Targretin----[1] 13 💬
2394Taurine[1] Taurine[1] Taurine 💬 --[4] 13, 21, 201, 337 💬
2395TCD after bosentan administration[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
2396TCD baseline----[1] 13 💬
2397Tcelna----[1] 13 💬
2398TECFIDERA----[1] 13 💬
2399Tecfidera (BG00012)----[1] 13 💬
2400Tecfidera (BG12)----[1] 13 💬
2401TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE----[1] 13 💬
2402Tecfidera 240MG CPS ETD----[1] 13 💬
2403Tecfidera®----[1] 13 💬
2404Tecfidera® 120 mg----[1] 13 💬
2405Tecfidera® 120mg magensaftresistente Hartkapseln----[1] 13 💬
2406Tecfidera® 240 mg----[1] 13 💬
2407Tecfidera® 240mg magensaftresistente Hartkapseln----[1] 13 💬
2408Tecifdera (dimethyl fumarate)[1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[1] 13 💬
2409Telitacicept[1] Telitacicept---[14] 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
2410TEMELIMAB[1] Temelimab---[1] 13 💬
2411Temsirolimus[1] Temsirolimus[1] Temsirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[4] 13, 34, 89, 331 💬
2412Temsirolimus Tablets[1] Temsirolimus[1] Temsirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 13 💬
2413Tenofovir[1] Tenofovir[1] Tenofovir 💬 --[8] 2, 6, 13, 25, 26, 93, 265, 325 💬
2414Tenofovir alafenamide[2] Tenofovir,
Tenofovir alafenamide		[3] Tenofovir ,
Tenofovir alafenamide ,
Tenofovir alafenamide fumarate 💬 		--[2] 2, 13 💬
2415TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY][2] Tenofovir,
Tenofovir alafenamide		[3] Tenofovir ,
Tenofovir alafenamide ,
Tenofovir alafenamide fumarate 💬 		--[1] 13 💬
2416TERIFLUNOMIDE[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[4] 13, 25, 26, 63 💬
2417Teriflunomide (HMR1726)[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 13 💬
2418Teriflunomide 14 MG[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 13 💬
2419Teriflunomide 14 MG Oral Tablet [Aubagio][1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 13 💬
2420Teriflunomide capsule[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 13 💬
2421TERIFLUNOMIDE HMR1726[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 13 💬
2422TeriflunomideProduct Code: HMR1726Pharmaceutical Form: Film-coated tabletINN or Proposed INN: TERIFLUNOMIDECAS Number: 108605-62-5Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 14-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: TeriflunomideProduct Code: HMR1726Pharmaceutical Form: Film-coated tabletINN or Proposed INN: TERIFLUNOMIDECAS Number: 108605-62-5Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 7-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: TeriflunomideProduct Code: HMR1726Pharmaceutical Form: Film-coated tabletINN or Proposed INN: TERIFLUNOMIDECAS Number: 108605-62-5Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 3.5-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 13 💬
2423Tesla Brain MRI----[1] 13 💬
2424Testosterone[1] Testosterone[1] Testosterone 💬 [1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[9] 1, 2, 3, 13, 60, 76, 78, 113, 265 💬
2425TESTOSTERONE UNDECANOATE[2] Testosterone,
Testosterone undecanoate		[2] Testosterone ,
Testosterone undecanoate 💬 		[1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[2] 13, 60 💬
2426Tetanus diphtheria toxoid vaccine (Td)----[1] 13 💬
2427Tetanus diphtheria toxoids vaccine----[1] 13 💬
2428Tetanus toxoid (TT) containing vaccine (Td, Tdap)----[1] 13 💬
2429Tetanus toxoid vaccine----[1] 13 💬
2430Tetanus, diphtheria, and acellular pertussis vaccine[1] Pertussis vaccine[1] Pertussis vaccine 💬 --[1] 13 💬
2431Tetracycline[1] Tetracycline[2] Tetracycline ,
Tetracycline hydrochloride 💬 		--[5] 13, 46, 53, 66, 97 💬
2432Tetracycline - Statin - Antimycotic[1] Tetracycline[2] Tetracycline ,
Tetracycline hydrochloride 💬 		--[1] 13 💬
2433Tetrahydrocannabinol (THC)----[1] 13 💬
2434TETRAHYDROCANNABINOL Botanical Drug Substance (THC BDS)----[1] 13 💬
2435TG-1101----[1] 13 💬
2436THC----[2] 13, 36 💬
2437Thiamine[1] Thiamine[3] Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--[5] 8, 13, 93, 265, 340 💬
2438THIOPLEX----[1] 13 💬
2439Thiotepa[1] Thiotepa[1] Thiotepa 💬 --[14] 13, 19, 20, 28, 46, 51, 60, 65, 85, 96, 107, 164, 284, 285 💬
2440THYMOGLOBULINE----[5] 13, 36, 51, 60, 96 💬
2441Thymoglobuline®----[1] 13 💬
2442Thymol[1] Thymol[1] Thymol 💬 --[1] 13 💬
2443Tissue Selective Estrogen Complex----[1] 13 💬
2444Tizanidine[1] Tizanidine[2] Tizanidine hydrochloride ,
Tizanidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
2445Tizanidine (sublingual or oral)[1] Tizanidine[2] Tizanidine hydrochloride ,
Tizanidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
2446Tizanidine hydrochloride capsule[1] Tizanidine[2] Tizanidine hydrochloride ,
Tizanidine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
2447TMP001----[1] 13 💬
2448Tocilizumab[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[26] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
2449Tocilizumab Injection[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 11, 13 💬
2450Tocopherol[1] Tocopherol[1] Tocopherol 💬 --[7] 13, 49, 71, 206, 215, 257, 298 💬
2451TolDC - intradermal----[1] 13 💬
2452TolDC - intranodal----[1] 13 💬
2453Tolebrutinib[1] Tolebrutinib[1] Tolebrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
2454Tolebrutinib 120mg[1] Tolebrutinib[1] Tolebrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬
2455Tolebrutinib 60mg[1] Tolebrutinib[1] Tolebrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬
2456Tolerogenic dendritic cells (tolDC)----[1] 13 💬
2457Tolerogenic Dendritic cells loaded with myelin peptides----[1] 13 💬
2458Tolerogenic Fibroblasts----[1] 13 💬
2459Tolperisone[1] Tolperisone[2] Tolperisone hydrochloride ,
Tolperisone 💬 		--[1] 13 💬
2460Tolperisone HC1[1] Tolperisone[2] Tolperisone hydrochloride ,
Tolperisone 💬 		--[1] 13 💬
2461Tolperisone HCl[1] Tolperisone[2] Tolperisone hydrochloride ,
Tolperisone 💬 		--[1] 13 💬
2462Tolpersan----[1] 13 💬
2463Tolposan----[1] 13 💬
2464Topical Preparation H arm----[1] 13 💬
2465TORVAST*10CPR 10MG----[1] 13 💬
2466Tovaxin----[1] 13 💬
2467Tovaxin Autologous T Cell Vaccine----[1] 13 💬
2468Tracleer----[8] 13, 51, 84, 85, 86, 88, 210, 211 💬
2469Trancopal Dolo----[1] 13 💬
2470Transcranial magnetic motor evoked potentials (TCmMEP)----[1] 13 💬
2471Transcranial Magnetic Stimulation----[2] 13, 77 💬
2472Transcranial Magnetic Stimulation (TMS)----[1] 13 💬
2473Trap Myelin Test----[1] 13 💬
2474Treatment withdrawal----[1] 13 💬
2475TREOSULFAN[1] Treosulfan[1] Treosulfan 💬 --[6] 13, 19, 62, 65, 284, 286 💬
2476Trichuris suis eggs----[3] 13, 96, 97 💬
2477Trichuris suis Ova----[4] 13, 46, 96, 97 💬
2478Trichuris suis ova (eggs), embryonated, viable----[1] 13 💬
2479Trileptal----[1] 13 💬
2480Triomar™ (omega-3 fatty acids)[1] Omega-3 fatty acids---[1] 13 💬
2481Trivalent seasonal influenza vaccine----[1] 13 💬
2482Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere----[1] 13 💬
2483Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.----[1] 13 💬
2484Truvada (tenofovir/emtricitabine)[2] Emtricitabine,
Tenofovir		[2] Emtricitabine ,
Tenofovir 💬 		--[1] 13 💬
2485TRX319----[1] 13 💬
2486TSO----[3] 13, 46, 97 💬
2487TT Vaccine----[1] 13 💬
2488Turkey[1] Turkey---[2] 13, 53 💬
2489TV-5010----[1] 13 💬
2490TV-5600----[3] 8, 13, 96 💬
2491Tylenol Pill----[1] 13 💬
2492Tyruko Injectable Product----[1] 13 💬
2493TYSABRI----[3] 13, 25, 63 💬
2494TYSABRI 300 mg concentrado para solución para perfusión----[1] 13 💬
2495TYSABRI 300 mg concentrate for solution for infusion----[1] 13 💬
2496TYSABRI 300 mg solution à diluer pour perfusion----[1] 13 💬
2497TYSABRI and AVONEX----[1] 13 💬
2498Tysabri ® (Natalizumab)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
2499TYSABRI*IV 1FL 300MG 15ML----[1] 13 💬
2500TYSABRI®----[1] 13 💬
2501Tysabri® (natalizumab)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
2502UBLITUXIMAB[1] Ublituximab[1] Ublituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
2503Ubltuximab----[1] 13 💬
2504UCAR T-cell----[7] 11, 13, 14, 49, 51, 66, 222 💬
2505Ucb L059----[1] 13 💬
2506UK: Sativex Oromucosal Spray----[1] 13 💬
2507Ultomiris----[7] 2, 11, 13, 50, 62, 66, 109 💬
2508ULTOMIRIS®----[1] 13 💬
2509Ultra small particles of iron oxide (USPIO)----[1] 13 💬
2510Ultrasmall particles of iron oxide----[1] 13 💬
2511Ultromiris----[1] 13 💬
2512Umbilical cord derived Mesenchymal Stem Cells----[1] 13 💬
2513Umbilical cord mesenchymal stem cells----[5] 13, 46, 57, 97, 113 💬
2514Uncoupled RBCs----[1] 13 💬
2515UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS----[1] 13 💬
2516Universal BCMA CAR-T----[3] 11, 13, 14 💬
2517Universal BCMA-CD19 CART----[1] 13 💬
2518Universal CD19 CAR-?dT Cell Injection----[3] 11, 13, 14 💬
2519Universal CD19 CAR-T----[3] 11, 13, 14 💬
2520Universal STAR-T Cell Injection----[1] 13 💬
2521Untreated to atorvastatin treatment[1] Atorvastatin[2] Atorvastatin calcium ,
Atorvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
2522Uplizna----[3] 11, 13, 300 💬
2523Urbason 40 mg----[1] 13 💬
2524URBASON 40 mg comprimidos----[1] 13 💬
2525URBASON FORTE----[1] 13 💬
2526Urbason solubile forte 1000mg----[1] 13 💬
2527Urbason® solubile forte 1000 mg----[1] 13 💬
2528Urine samples----[1] 13 💬
2529US-Ocrevus----[1] 13 💬
2530Usual DMT continuation----[1] 13 💬
2531UVEDOSE----[2] 13, 46 💬
2532UVEDOSE 100 000 UI----[1] 13 💬
2533UVEDOSE 100 000 UI, solution buvable en ampoule----[1] 13 💬
2534UVEDOSE 2,5mg (100000UI)----[1] 13 💬
2535UVEDOSE 2.5mg (100 000 UI)----[1] 13 💬
2536V08CA02----[1] 13 💬
2537V08CA09----[1] 13 💬
2538Vaginal estriol[1] Estriol[2] Estriol ,
Estriol tripropionate 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
2539Vancomycin[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[9] 6, 13, 46, 70, 94, 96, 97, 296, 299 💬
2540Vardenafil[1] Vardenafil[2] Vardenafil ,
Vardenafil hydrochloride 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[3] 13, 86, 299 💬
2541Vardenafil (hidrocloride)[1] Vardenafil[2] Vardenafil ,
Vardenafil hydrochloride 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 13 💬
2542VARDENAFILO HIDROCLORURO[1] Vardenafil[2] Vardenafil ,
Vardenafil hydrochloride 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 13 💬
2543Vatelizumab[1] Vatelizumab---[2] 13, 97 💬
2544VAY736----[9] 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
2545VB13S1----[1] 13 💬
2546VB5S2----[1] 13 💬
2547VB6S5----[1] 13 💬
2548Vehicle Gel----[2] 13, 34 💬
2549Venlafaxin Hexal----[1] 13 💬
2550Venlafaxine[1] Venlafaxine[3] Venlafaxine hydrochloride ,
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		[2] SLC6A2,
SLC6A4 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[4] 6, 13, 46, 97 💬
2551VENLAFAXINE HYDROCHLORIDE[1] Venlafaxine[3] Venlafaxine hydrochloride ,
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		[2] SLC6A2,
SLC6A4 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[2] 13, 46 💬
2552Verum arm receiving Gilenya®----[1] 13 💬
2553Verum arm receiving Vitamin D oil[1] Vitamin D---[1] 13 💬
2554VESIcare 10Mg Tablet----[1] 13 💬
2555VIB0551----[1] 13 💬
2556Video game therapy----[1] 13 💬
2557Vidofludimus[1] Vidofludimus[2] Vidofludimus ,
Vidofludimus calcium 💬 		[1] DHODH 💬 [1] Pyrimidine metabolism 💬[5] 13, 46, 94, 96, 97 💬
2558VIDOFLUDIMUS CALCIUM[2] Calcium,
Vidofludimus		[2] Vidofludimus ,
Vidofludimus calcium 💬 		[1] DHODH 💬 [1] Pyrimidine metabolism 💬[4] 13, 94, 96, 97 💬
2559Vigantol----[2] 13, 65 💬
2560Vigantol Oel----[3] 13, 96, 97 💬
2561VIGANTOL OIL----[1] 13 💬
2562VigantOL oil plus interferon beta-1a (Rebif)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
2563Vigantol® Oil----[1] 13 💬
2564Vigantol® Öl 20.000 I.E./ml----[1] 13 💬
2565Visual Evoked Potential (VEP)----[1] 13 💬
2566Vitamin A[1] Vitamin A[2] Vitamin A oil ,
Vitamin A 💬 		[2] RARA,
RARB 💬 		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[4] 13, 53, 90, 97 💬
2567Vitamin D[1] Vitamin D---[26] 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
2568Vitamin D3----[12] 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
2569Vitamin E[1] Vitamin E[1] Vitamin E 💬 --[12] 2, 6, 13, 19, 20, 46, 90, 96, 97, 206, 299, 317 💬
2570Vitamin E/Selenium[2] Selenium,
Vitamin E		[1] Vitamin E 💬 --[1] 13 💬
2571VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA----[1] 13 💬
2572Vivitrol Injectable Product----[1] 13 💬
2573Vivomixx®----[1] 13 💬
2574VSN16R----[1] 13 💬
2575VSN16R 100mg----[1] 13 💬
2576VT7208----[1] 13 💬
2577VX15/2503----[2] 8, 13 💬
2578Warfarin[1] Warfarin[3] Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		[2] NQO1,
VKORC1 💬 		[5] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[15] 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
2579Warm compress prior to injection of glatiramer acetate[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
2580Water[1] Water[1] Water 💬 --[36] 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
2581WAY-130799----[1] 13 💬
2582Withhold IS (B cell depletion therapy)----[7] 13, 35, 46, 49, 50, 51, 107 💬
2583Withhold IS (MMF or MPA)----[7] 13, 35, 46, 49, 50, 51, 107 💬
2584Withhold IS (MTX)----[7] 13, 35, 46, 49, 50, 51, 107 💬
2585Wristband physical activity monitor----[1] 13 💬
2586XBD173----[1] 13 💬
2587XCEL-MC-ALPHA----[1] 13 💬
2588Xeomin----[7] 5, 6, 7, 13, 15, 17, 113 💬
2589XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector----[1] 13 💬
2590Yishen Daluo Yin granuls----[1] 13 💬
2591Zanubrutinib[1] Zanubrutinib[1] Zanubrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[7] 13, 48, 61, 63, 222, 300, 331 💬
2592Zenapax----[1] 13 💬
2593Zeposia----[1] 13 💬
2594Zeposia 0,92 mg capsule rigide----[1] 13 💬
2595ZEPOSIA® indicated for the treatment of: Relapsing forms of multiple sclerosis, and active ulcerative colitis in adults----[2] 13, 97 💬
2596Zinbryta----[1] 13 💬
2597ZK 157046----[1] 13 💬
2598ZOL446H----[1] 13 💬
2599Zoledronic acid[1] Zoledronic acid[5] Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[16] 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬
2600ZOLEDRONIC ACID MONOHYDRATE[1] Zoledronic acid[5] Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[1] 13 💬